amphetamine has been researched along with Amphetamine Abuse in 274 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Zelen II design method was used; 124 patients with acute mental disorders due to amphetamine were randomly divided into olanzapine group (n = 63) and haloperidol group (n = 61)." | 9.27 | Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial. ( Chen, X; Fan, Q; Song, Y; Tang, J; Xue, X; Yu, X, 2018) |
| " This review examined laboratory data collected in humans, who were administered an acute dose of amphetamine or methamphetamine, in order to investigate the link between amphetamines and aggression." | 9.22 | Methamphetamine, amphetamine, and aggression in humans: A systematic review of drug administration studies. ( Casey, S; Downey, LA; Hart, CL; O'Malley, KY, 2022) |
| " In a double-blind, randomly stratified clinical trial investigating whether add-on dextromethorphan (60-120 mg/day) attenuated inflammation and the combined use of opioids in heroin-dependent patients undergoing methadone maintenance treatment, we evaluated whether inflammation is related to the progression of opioid dependence." | 9.16 | Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment. ( Chang, YH; Chen, PS; Chen, SH; Chen, SL; Chu, CH; Hong, JS; Lee, IH; Lee, SY; Lu, RB; Tao, PL; Yang, YK; Yeh, TL, 2012) |
| "This study examines whether illicit amphetamine use is associated with differences in the prevalence of specific psychiatric symptoms in a community sample of individuals diagnosed with schizophrenia or affective psychotic disorders." | 7.88 | The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses. ( Burns, R; Calabria, B; Castle, D; McKetin, R; Voce, A, 2018) |
| "To study the content variation of selegiline and its metabolites in urine, and based on actual cases, to explore the feasibility for the identification of methamphetamine abuse and selegiline use by chiral analysis." | 7.85 | [Identification of Methamphetamine Abuse and Selegiline Use： Chiral Analysis of Methamphetamine and Amphetamine in Urine]. ( Bu, J; Qiao, Z; Shen, M; Wu, HJ; Xiang, P; Zhuo, XY, 2017) |
| "Withdrawal from amphetamine is associated with increased anxiety and sensitivity to stressors which are thought to contribute to relapse." | 7.80 | Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal. ( Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ, 2014) |
| "False positive urinalysis towards amphetamine/methamphetamine by immunoassay and presence of sympathomimetic effects may contribute to a false diagnosis of this drug poisoning." | 7.79 | [Acute poisoning with weight-loss dietary supplement falsely suggesting the use of amphetamine]. ( Sommerfeld, K; Tezyk, A; Zielińska-Psuja, B; Łukasik-Głebocka, M, 2013) |
| "We present a case showing that intake of amphetamine can cause severe anterior myocardial infarction with acute severe pump failure." | 7.74 | [Severe anterior myocardial infarction caused by amphetamine abuse]. ( Baandrup, U; Bøttcher, M; Christensen, TD; Eiskjaer, HE; Ilkjaer, LB; Lorenzen, AG; Zebis, LP, 2007) |
| "We report a case of intracranial hemorrhage due to amphetamine abuse in a young adult." | 7.74 | [Case of intracerebral hemorrhage due to amphetamine abuse]. ( Fujii, R; Hara, T; Kurokawa, S; Maruki, C; Ohno, S; Tomita, Y; Tsunoda, A, 2008) |
| "To examine trends in pregnancy hospitalizations with a diagnosis of amphetamine or cocaine abuse and the prevalence of associated medical complications." | 7.74 | Hospitalizations with amphetamine abuse among pregnant women. ( Cox, S; Jamieson, DJ; Kourtis, AP; Posner, SF, 2008) |
| " Liquid chromatography with mass spectrometry was instrumental in the identification and quantitative determination of amphetamine within an intracerebral hematoma that had persisted for 13 days." | 7.73 | Intracerebral hemorrhage associated with amphetamine. ( Klys, M; Konopka, T; Rojek, S, 2005) |
| " One potentially critical issue relates to pharmacokinetic differences between the species." | 6.41 | Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. ( Cho, AK; Kuczenski, R; Melega, WP; Segal, DS, 2001) |
| "Myocardial infarction is an infrequent condition in young adults." | 5.42 | Amphetamine-related myocardial infarction in a 42-year old man. ( Berent, J; Smędra, A; Szustowski, S, 2015) |
| "Amphetamine is a major drug of abuse in Sweden and in the other Nordic countries." | 5.39 | Amphetamine abuse in Sweden: subject demographics, changes in blood concentrations over time, and the types of coingested substances. ( Holmgren, A; Jones, AW, 2013) |
| "Long-term amphetamine and methamphetamine dependence has been linked to cerebral blood perfusion, metabolic, and white matter abnormalities." | 5.36 | Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness. ( Agartz, I; Bjerkan, PS; Franck, J; Hammarberg, A; Jayaram-Lindström, N; Lawyer, G, 2010) |
| "Transient left ventricular apical ballooning syndrome was first described in Japan as "Takotsubo cardiomyopathy." | 5.35 | Reverse or inverted left ventricular apical ballooning syndrome (reverse Takotsubo cardiomyopathy) in a young woman in the setting of amphetamine use. ( Mostafizi, K; Movahed, MR, 2008) |
| "The Zelen II design method was used; 124 patients with acute mental disorders due to amphetamine were randomly divided into olanzapine group (n = 63) and haloperidol group (n = 61)." | 5.27 | Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial. ( Chen, X; Fan, Q; Song, Y; Tang, J; Xue, X; Yu, X, 2018) |
| " This review examined laboratory data collected in humans, who were administered an acute dose of amphetamine or methamphetamine, in order to investigate the link between amphetamines and aggression." | 5.22 | Methamphetamine, amphetamine, and aggression in humans: A systematic review of drug administration studies. ( Casey, S; Downey, LA; Hart, CL; O'Malley, KY, 2022) |
| "Thirty patients admitted with heart failure and echocardiographic evidence of cardiomyopathy between 2005 and 2014 and who had a documented history of amphetamine abuse that was considered an important factor in the causation of their cardiomyopathy were retrospectively identified." | 5.22 | Clinical Characteristics and Outcomes of Patients with Amphetamine-Associated Cardiomyopathy in South Auckland, New Zealand. ( Bradley, J; Gabriel, RS; Kerr, AJ; Kueh, SA; Looi, JL; Lund, M; Sutton, T, 2016) |
| " In a double-blind, randomly stratified clinical trial investigating whether add-on dextromethorphan (60-120 mg/day) attenuated inflammation and the combined use of opioids in heroin-dependent patients undergoing methadone maintenance treatment, we evaluated whether inflammation is related to the progression of opioid dependence." | 5.16 | Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment. ( Chang, YH; Chen, PS; Chen, SH; Chen, SL; Chu, CH; Hong, JS; Lee, IH; Lee, SY; Lu, RB; Tao, PL; Yang, YK; Yeh, TL, 2012) |
| "Methamphetamine abuse and dependence are significant public-health concerns." | 5.15 | Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. ( Glaser, PE; Hays, LR; Lile, JA; Rush, CR; Stoops, WW, 2011) |
| "Amphetamine exposure in pregnancy is associated with adverse birth outcomes and should be identified by physicians providing antenatal care." | 4.87 | Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis. ( Ladhani, NN; Murphy, KE; Shah, PS, 2011) |
| " COMT, D4 receptor, and BDNF polymorphisms are linked to methamphetamine abuse and psychosis." | 4.85 | Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. ( Haile, CN; Kosten, TA; Kosten, TR, 2009) |
| "The patients showing amphetamine abuse in maintenance therapy had a greater impulsiveness than those having other simple maintenance treatments, and patients under MMT may be more addicted to amphetamines in comparison with those having BMT." | 4.02 | The Abuse Characteristics of Amphetamine-Type Stimulants in Patients Receiving Methadone Maintenance Treatment and Buprenorphine Maintenance Treatment. ( Li, L; Liu, N; Liu, Y; Shen, W; Xu, L; Zhou, W, 2021) |
| "This study examines whether illicit amphetamine use is associated with differences in the prevalence of specific psychiatric symptoms in a community sample of individuals diagnosed with schizophrenia or affective psychotic disorders." | 3.88 | The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses. ( Burns, R; Calabria, B; Castle, D; McKetin, R; Voce, A, 2018) |
| "To study the content variation of selegiline and its metabolites in urine, and based on actual cases, to explore the feasibility for the identification of methamphetamine abuse and selegiline use by chiral analysis." | 3.85 | [Identification of Methamphetamine Abuse and Selegiline Use： Chiral Analysis of Methamphetamine and Amphetamine in Urine]. ( Bu, J; Qiao, Z; Shen, M; Wu, HJ; Xiang, P; Zhuo, XY, 2017) |
| "Amphetamine abuse is increasing worldwide, and the occurrence of amphetamine-induced (AI) psychiatric issues further complicates treatment." | 3.83 | The prevalence and clinical features of amphetamine-induced obsessive compulsive disorder. ( Alikhani, M; Bajoghli, H; Brand, S; Farnia, V; Holsboer-Trachsler, E; Juibari, TA; Karimi, AR; Shakeri, J; Tatari, F, 2016) |
| "These data confirm that oral fluid is a viable alternative to urine for monitoring amphetamine abuse, and that these substances might be detected in oral fluid for at least 1 week after ingestion of high doses." | 3.83 | Extended Detection of Amphetamine and Methamphetamine in Oral Fluid. ( Andås, HT; Christophersen, AS; Enger, A; Huestis, MA; Vindenes, V; Øiestad, ÅM; Øiestad, EL, 2016) |
| "We observed differences of amphetamine versus methamphetamine loads (expressed as mg/day/1000 inhabitants): Amphetamine loads were much higher in all tested WWTPs indicating a low prevalence of methamphetamine abuse in the federal state of Saarland at the tested period." | 3.81 | Prevalence and distribution patterns of amphetamine and methamphetamine consumption in a federal state in southwestern Germany using wastewater analysis. ( Hasselbach, R; Meyer, MR; Vollerthun, T, 2015) |
| "Withdrawal from amphetamine is associated with increased anxiety and sensitivity to stressors which are thought to contribute to relapse." | 3.80 | Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal. ( Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ, 2014) |
| "False positive urinalysis towards amphetamine/methamphetamine by immunoassay and presence of sympathomimetic effects may contribute to a false diagnosis of this drug poisoning." | 3.79 | [Acute poisoning with weight-loss dietary supplement falsely suggesting the use of amphetamine]. ( Sommerfeld, K; Tezyk, A; Zielińska-Psuja, B; Łukasik-Głebocka, M, 2013) |
| "We report a case of intracranial hemorrhage due to amphetamine abuse in a young adult." | 3.74 | [Case of intracerebral hemorrhage due to amphetamine abuse]. ( Fujii, R; Hara, T; Kurokawa, S; Maruki, C; Ohno, S; Tomita, Y; Tsunoda, A, 2008) |
| "We present a case showing that intake of amphetamine can cause severe anterior myocardial infarction with acute severe pump failure." | 3.74 | [Severe anterior myocardial infarction caused by amphetamine abuse]. ( Baandrup, U; Bøttcher, M; Christensen, TD; Eiskjaer, HE; Ilkjaer, LB; Lorenzen, AG; Zebis, LP, 2007) |
| "To examine trends in pregnancy hospitalizations with a diagnosis of amphetamine or cocaine abuse and the prevalence of associated medical complications." | 3.74 | Hospitalizations with amphetamine abuse among pregnant women. ( Cox, S; Jamieson, DJ; Kourtis, AP; Posner, SF, 2008) |
| " Liquid chromatography with mass spectrometry was instrumental in the identification and quantitative determination of amphetamine within an intracerebral hematoma that had persisted for 13 days." | 3.73 | Intracerebral hemorrhage associated with amphetamine. ( Klys, M; Konopka, T; Rojek, S, 2005) |
| "Withdrawal from chronic amphetamine administration results in behavioral changes that may be analogous to some aspects of depression in humans, such as reward deficits (i." | 3.72 | Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. ( Cryan, JF; Hoyer, D; Markou, A, 2003) |
| " The aim of the current experiment was to investigate the consequences of repeated withdrawal from ethanol on amphetamine-induced behaviours in the rat and compare this with animals with electrical kindling of the amygdala, a procedure that has been shown to enhance alcohol withdrawal seizures [Pinel et al." | 3.71 | Consequences of amygdala kindling and repeated withdrawal from ethanol on amphetamine-induced behaviours. ( Dunworth, SJ; Ripley, TL; Stephens, DN, 2002) |
| "The symptom of "diminished interest or pleasure" in rewarding stimuli is an affective symptom of nicotine and amphetamine withdrawal, and a core symptom of depression." | 3.71 | Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. ( Harrison, AA; Liem, YT; Markou, A, 2001) |
| "The study of the effects of repeated amphetamine administration and withdrawal on brain reward function has relevance to both amphetamine dependence and non-drug-induced depressions." | 3.70 | Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. ( Markou, A; Myers, C; Paterson, NE, 2000) |
| "Methylphenidate is an effective treatment for reducing intravenous drug use in patients with severe amphetamine dependence." | 2.73 | A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. ( Föhr, J; Haukka, J; Kuikanmäki, O; Kuoppasalmi, K; Meririnne, E; Sokero, P; Tiihonen, J; Tuomola, P; Vorma, H, 2007) |
| " Both amfetamine and methamfetamine studies showed good tolerability of naltrexone, with few adverse events seen." | 2.61 | Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials. ( Anand, S; Chan, EW; Lam, L; Li, X; Tse, ML; Zhao, JX, 2019) |
| "Amphetamine and methamphetamine addiction is described by specific behavioral alterations, suggesting long-lasting changes in gene and protein expression within specific brain subregions involved in the reward circuitry." | 2.52 | Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. ( Cadet, JL; Godino, A; Jayanthi, S, 2015) |
| "Amphetamine was discovered over 100 years ago." | 2.49 | Amphetamine, past and present--a pharmacological and clinical perspective. ( Gosden, J; Heal, DJ; Nutt, DJ; Smith, SL, 2013) |
| "There are many factors that impact substance use in young people in the Pacific Island Countries and Territories (PICTs)." | 2.47 | Alcohol, cannabis and amphetamine-type stimulants use among young Pacific Islanders. ( Ali, H; Howard, J; Robins, L, 2011) |
| " One potentially critical issue relates to pharmacokinetic differences between the species." | 2.41 | Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. ( Cho, AK; Kuczenski, R; Melega, WP; Segal, DS, 2001) |
| "To explore the relationship between sleep deprivation and amphetamine-induced psychosis." | 1.72 | Sleep Deprivation & Amphetamine Induced Psychosis. ( Alshehri, MH; Bahanan, AO; Elag, KA; Shalaby, AS, 2022) |
| "Amphetamine (AMPH) is an addictive psychostimulant highly used worldwide and its consumption is related to neurotoxic effects." | 1.62 | Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats. ( Burger, ME; da Rosa, JLO; Metz, VG; Milanesi, LH; Pase, CS; Rossato, DR, 2021) |
| "Methamphetamine (MA) is a highly addictive central nervous system stimulant." | 1.56 | Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair. ( Jang, WJ; Jeong, CH; Kim, S; Lee, S; Seo, MJ; Song, SH, 2020) |
| "Amphetamine (AMPH) abuse is a serious public health problem due to the high addictive potential of this drug, whose use is related to severe brain neurotoxicity and memory impairments." | 1.51 | Omega-3 decreases D1 and D2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats. ( Barcelos, RCS; Burger, ME; Dias, VT; Emanuelli, T; Maurer, LH; Metz, VG; Pase, CS; Segat, HJ; Stiebe, J, 2019) |
| "Mexiletine has been suggested as a cause of false-positive amphetamine results, but never confirmed as the causative agent in previous reports." | 1.48 | False-positive amphetamine results on several drug screening platforms due to mexiletine. ( Harnish, TL; Jannetto, PJ; Kaleta, EJ; Langman, LJ; Linkenmeyer, JJ; Snozek, CLH; Stephen, J, 2018) |
| " However, their chronic use is related to memory loss, emotional instability, insomnia, psychosis and paranoia." | 1.46 | Influence of physical activity on addiction parameters of rats exposed to amphetamine which were previously supplemented with hydrogenated vegetable fat. ( Antoniazzi, CTD; Barcelos, RCS; Burger, ME; Emanuelli, T; Kronbauer, M; Metz, VG; Piccolo, JC; Rosa, HZ; Roversi, K; Segat, HJ; Veit, JC; Vey, LT, 2017) |
| "Amphetamine (AMPH) abuse is a world concern and a serious public health problem." | 1.43 | m-Trifluoromethyl-diphenyldiselenide as a pharmacological tool to treat preference symptoms related to AMPH-induced dependence in rats. ( Barcelos, RCS; Brüning, CA; Burger, ME; Martini, F; Nogueira, CW; Segat, HJ, 2016) |
| "Myocardial infarction is an infrequent condition in young adults." | 1.42 | Amphetamine-related myocardial infarction in a 42-year old man. ( Berent, J; Smędra, A; Szustowski, S, 2015) |
| "Amphetamine treatment during adolescence causes long-term cognitive deficits in rats." | 1.39 | Periadolescent amphetamine treatment causes transient cognitive disruptions and long-term changes in hippocampal LTP depending on the endogenous expression of pleiotrophin. ( Del Olmo, N; Fole, A; Gramage, E; Herradón, G; Martín, YB, 2013) |
| "The development of amphetamine dependence largely depends on the effects of amphetamine in the brain reward systems." | 1.39 | Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence. ( Engel, JA; Franck, J; Jayaram-Lindström, N; Jerlhag, E; Nilsson, S; Rosengren, A; Suchankova, P; Toren, K, 2013) |
| "Amphetamine is a major drug of abuse in Sweden and in the other Nordic countries." | 1.39 | Amphetamine abuse in Sweden: subject demographics, changes in blood concentrations over time, and the types of coingested substances. ( Holmgren, A; Jones, AW, 2013) |
| "Amphetamine has a significant potential for abuse and addiction." | 1.39 | Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain. ( Andreazza, AC; Che, Y; Cui, YH; Tan, H; Wang, JF; Young, LT, 2013) |
| "Long-term amphetamine and methamphetamine dependence has been linked to cerebral blood perfusion, metabolic, and white matter abnormalities." | 1.36 | Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness. ( Agartz, I; Bjerkan, PS; Franck, J; Hammarberg, A; Jayaram-Lindström, N; Lawyer, G, 2010) |
| "Amphetamine analogues were identified by high performance liquid chromatography with diode array detector (HPLC-DAD)." | 1.35 | [Amphetamine and its analogues determination in urine from patients hospitalized in the Department of Toxicology Jagiellonian University Collegium Medicum in Krakow]. ( Gawlikowski, T; Gomółka, E; Król, A, 2009) |
| "Low amphetamine doses have been associated with enhanced performance in studies of sleep-deprived subjects." | 1.35 | [Driving under the influence of amphetamine and metamphetamine]. ( Lia, K; Slørdal, L; Spigset, O, 2009) |
| "Amphetamine treatment increased CRF(2) receptor densities in most subregions of the dRN, and CRF(2) receptors were still elevated following 6 weeks of withdrawal." | 1.35 | Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus. ( Forster, GL; Lukkes, JL; Mouw, NJ; Pringle, RB, 2008) |
| "Transient left ventricular apical ballooning syndrome was first described in Japan as "Takotsubo cardiomyopathy." | 1.35 | Reverse or inverted left ventricular apical ballooning syndrome (reverse Takotsubo cardiomyopathy) in a young woman in the setting of amphetamine use. ( Mostafizi, K; Movahed, MR, 2008) |
| "Amphetamine was present in 15,898 of 26,556 cases of DUID (60%) either alone or together with other licit or illicit drugs." | 1.35 | Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood. ( Holmgren, A; Jones, AW; Kugelberg, FC, 2008) |
| " If these findings can be shown to extend to mammals, beta-lactam antibiotics might represent a novel pharmacotherapy or adjunct approach for treating drug abuse or serve as a template for drug discovery efforts aimed at treating drug abuse, recovery from drug abuse, or ameliorating the withdrawal from chronic use of therapeutic medications." | 1.35 | The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians. ( Capasso, A; Cavallo, F; Ding, Z; Raffa, RB; Rawls, SM, 2008) |
| " The AMPH-suppressed SIP manifested again following 5-days of pretreatment with a sub-threshold dosage of AMPH (1." | 1.35 | Role of dopaminergic DAD1 and DAD2 receptors in the sensitization of amphetamine-suppressed schedule-induced polydipsia in rats. ( Lin, PJ; Liu, YP; Tseng, CJ; Tung, CS; Wan, FJ, 2009) |
| "Methamphetamine (METH) is a psychostimulant that induces excessive release of dopamine (DA) in the striatum." | 1.33 | Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. ( Angulo, JA; Xu, W; Zhu, JP, 2005) |
| "Amphetamine was determined in blood and urine by gas chromatography-mass spectrometry with deuterium-labelled internal standards." | 1.33 | Relation between blood- and urine-amphetamine concentrations in impaired drivers as influenced by urinary pH and creatinine. ( Jones, AW; Karlsson, L, 2005) |
| " The aim of the present study was to investigate stress and AMPH- induced release of adrenocorticotropic hormone (ACTH) and corticosterone (CORT) during withdrawal from an escalating dosage schedule of AMPH known to produce depression-like effects in rats." | 1.33 | Amphetamine withdrawal leads to behavioral sensitization and reduced HPA axis response following amphetamine challenge. ( Feldon, J; Pryce, CR; Russig, H, 2006) |
| "When tested alone, only the Parkinson's disease group retained statistical significance (adjusted OR=8." | 1.33 | Amphetamine exposure is elevated in Parkinson's disease. ( Bekele, W; Christine, CW; Garwood, ER; McCulloch, CE, 2006) |
| "The 'heroin shortage' was unlikely to have been a simple correction at the end of a long period of reduced heroin availability, and represents a separate non-random shock which strongly affected the markets." | 1.33 | Identification and quantification of change in Australian illicit drug markets. ( Day, C; Degenhardt, L; Gilmour, S; Koch, I, 2006) |
| "Amphetamine-pretreated Ca(v)1." | 1.33 | Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. ( Giordano, TP; Kosofsky, BE; Rajadhyaksha, AM; Satpute, SS; Striessnig, J, 2006) |
| "Priapism is a "persistent erection not accompanied by sexual desire or stimulation, usually lasting more than six hours and typically involving only the corpora cavernosa." | 1.33 | Priapism and quetiapine: a case report. ( Dilley, JW; Harrison, G; Loeb, L; Nelson, K, 2006) |
| " The period of escalating doses (EDs) is likely associated with development of tolerance to aspects of METH's pharmacologic and toxic effects but the relative contributions of pharmacokinetic and pharmacodynamic factors have not been well defined." | 1.33 | Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge. ( Cho, AK; Kuczenski, R; Lacan, G; Melega, WP; O'Neil, ML; Segal, DS, 2006) |
| "The aim of this study was the assessment of disorders after chronic intake of psychoactive drugs, like marijuana, amphetamine, ecstasy, cocaine and opiates." | 1.32 | [Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units]. ( Chrostek Maj, J; Kamenczak, A; Kroch, S; Polewka, A; Szerszeń-Motyka, J, 2004) |
| "Amphetamine is an indirect dopamine receptor agonist and increases glutamate release in the striatum." | 1.31 | Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. ( Choe, ES; Chung, KT; Mao, L; Wang, JQ, 2002) |
| "In amphetamine-treated rats, a higher proportion of cortical cells fired in bursts, and a larger proportion of accumbens and prefrontal cortical neurons exhibited bistable membrane oscillations." | 1.31 | Amphetamine withdrawal alters bistable states and cellular coupling in rat prefrontal cortex and nucleus accumbens neurons recorded in vivo. ( Grace, AA; Onn, SP, 2000) |
| " Here we demonstrate that, after chronic administration of the psychostimulants cocaine and amphetamine, the transcription factor DeltaFosB is upregulated in the nucleus accumbens of periadolescent mice but not in post-weanling or adult mice." | 1.31 | Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine. ( Canas, E; Ehrlich, ME; Sommer, J; Unterwald, EM, 2002) |
| "Amphetamine sensitization was induced by six daily injections of amphetamine (3 mg/kg, i." | 1.31 | Incentive sensitization by previous amphetamine exposure: increased cue-triggered "wanting" for sucrose reward. ( Berridge, KC; Wyvell, CL, 2001) |
| " As expected, regular Wean-21 animals showed an AMPH-induced hyperactivity and a profile of conditioned locomotion, whereas the same dosage failed to induce any change in Wean-15 and Wean-27 groups." | 1.31 | Spontaneous novelty seeking and amphetamine-induced conditioning and sensitization in adult mice: evidence of dissociation as a function of age at weaning. ( Adriani, W; Laviola, G, 2002) |
| "Amphetamine was demonstrated in seven subjects." | 1.30 | Urinary excretion of amphetamine after termination of drug abuse. ( Mørland, J; Skuterud, B; Smith-Kielland, A, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (4.01) | 18.7374 |
| 1990's | 10 (3.65) | 18.2507 |
| 2000's | 126 (45.99) | 29.6817 |
| 2010's | 103 (37.59) | 24.3611 |
| 2020's | 24 (8.76) | 2.80 |
| Authors | Studies |
|---|---|
| Daldegan-Bueno, D | 1 |
| Maia, LO | 1 |
| Glass, M | 1 |
| Jutras-Aswad, D | 1 |
| Fischer, B | 1 |
| Chan, GCK | 1 |
| Sun, T | 1 |
| Lim, C | 1 |
| Stjepanović, D | 1 |
| Rutherford, B | 1 |
| Johnson, B | 1 |
| Hall, W | 1 |
| Leung, J | 1 |
| Polettini, AE | 1 |
| Sauer, C | 1 |
| Spieß, M | 1 |
| Schultis, W | 1 |
| Segat, HJ | 6 |
| Martini, F | 2 |
| Roversi, K | 5 |
| Rosa, SG | 1 |
| Muller, SG | 1 |
| Rossato, DR | 3 |
| Nogueira, CW | 2 |
| Burger, ME | 9 |
| Shalaby, AS | 1 |
| Bahanan, AO | 1 |
| Alshehri, MH | 1 |
| Elag, KA | 1 |
| O'Malley, KY | 1 |
| Hart, CL | 1 |
| Casey, S | 1 |
| Downey, LA | 1 |
| Opitz, A | 1 |
| Petasch, MS | 1 |
| Klappauf, R | 1 |
| Kirschgens, J | 1 |
| Hinz, J | 1 |
| Dittmann, L | 1 |
| Dathe, AS | 1 |
| Quednow, BB | 1 |
| Beste, C | 1 |
| Stock, AK | 1 |
| Zeng, R | 1 |
| Pu, HY | 1 |
| Zhang, XY | 1 |
| Yao, ML | 1 |
| Sun, Q | 1 |
| Balali-Mood, M | 1 |
| Sinclair, RD | 1 |
| Darchini-Maragheh, E | 1 |
| Etemad, L | 1 |
| Liu, S | 1 |
| Guo, X | 1 |
| Ma, S | 1 |
| Chen, Q | 1 |
| Wang, W | 4 |
| H Z, R | 1 |
| H J, S | 1 |
| R C S, B | 1 |
| Kr, R | 1 |
| R, RD | 1 |
| M E, B | 1 |
| Anderson, EM | 1 |
| McFadden, LM | 1 |
| Matuszewich, L | 1 |
| Nateghi, S | 1 |
| Effatpanah, H | 1 |
| Berlot, B | 1 |
| Williams, MGL | 1 |
| Bucciarelli-Ducci, C | 1 |
| Roset Ferrer, C | 1 |
| Gomila Muñiz, I | 1 |
| Elorza Guerrero, MÁ | 1 |
| Puiguriguer Ferrando, J | 1 |
| Leciñena Estean, MÁ | 1 |
| Tuero León, G | 1 |
| Sahuquillo Frías, L | 1 |
| Ripoll Vera, T | 1 |
| Socias Crespi, L | 1 |
| Sanchís Cortés, P | 1 |
| Barceló Martín, B | 1 |
| Martens, MS | 1 |
| Zurhold, H | 1 |
| Rosenkranz, M | 1 |
| O'Donnell, A | 1 |
| Addison, M | 1 |
| Spencer, L | 1 |
| McGovern, W | 1 |
| Gabrhelík, R | 1 |
| Petruželka, B | 1 |
| Rowicka, M | 1 |
| Liebregts, N | 1 |
| Degkwitz, P | 1 |
| Kaner, E | 1 |
| Verthein, U | 1 |
| Gerdtz, M | 1 |
| Yap, CYL | 1 |
| Daniel, C | 1 |
| Knott, JC | 1 |
| Kelly, P | 1 |
| Innes, A | 1 |
| Braitberg, G | 1 |
| Siefried, KJ | 1 |
| Acheson, LS | 1 |
| Lintzeris, N | 1 |
| Ezard, N | 1 |
| Rosa, HZ | 4 |
| Barcelos, RCS | 6 |
| de Brum, GF | 1 |
| Seo, MJ | 1 |
| Song, SH | 1 |
| Kim, S | 1 |
| Jang, WJ | 1 |
| Jeong, CH | 1 |
| Lee, S | 5 |
| Chawarski, MC | 1 |
| Hawk, K | 1 |
| Edelman, EJ | 1 |
| O'Connor, P | 1 |
| Owens, P | 1 |
| Martel, S | 1 |
| Coupet, E | 1 |
| Whiteside, L | 1 |
| Tsui, JI | 1 |
| Rothman, R | 1 |
| Cowan, E | 1 |
| Richardson, L | 1 |
| Lyons, MS | 1 |
| Fiellin, DA | 1 |
| D'Onofrio, G | 1 |
| Westbrook, SR | 1 |
| Carrica, LK | 1 |
| Banks, A | 1 |
| Gulley, JM | 2 |
| Metz, VG | 3 |
| da Rosa, JLO | 1 |
| Milanesi, LH | 1 |
| Pase, CS | 3 |
| Liu, Y | 2 |
| Liu, N | 1 |
| Shen, W | 1 |
| Li, L | 1 |
| Zhou, W | 1 |
| Xu, L | 1 |
| Wagner, D | 1 |
| Sauder, T | 1 |
| Koester, P | 1 |
| Gouzoulis-Mayfrank, E | 1 |
| Daumann, J | 1 |
| Dias, VT | 3 |
| Vey, LT | 4 |
| D'avila, LF | 2 |
| Antoniazzi, CTD | 1 |
| Kronbauer, M | 2 |
| Veit, JC | 1 |
| Piccolo, JC | 1 |
| Emanuelli, T | 2 |
| Hodes, A | 1 |
| Lifschytz, T | 1 |
| Rosen, H | 1 |
| Cohen Ben-Ami, H | 1 |
| Lichtstein, D | 1 |
| Turner, AC | 1 |
| Stramek, A | 1 |
| Kraev, I | 1 |
| Stewart, MG | 1 |
| Overton, PG | 1 |
| Dommett, EJ | 1 |
| Wang, T | 2 |
| Shen, B | 2 |
| Wu, H | 1 |
| Hu, J | 1 |
| Xu, H | 1 |
| Shen, M | 2 |
| Xiang, P | 3 |
| Bu, J | 1 |
| Qiao, Z | 1 |
| Zhuo, XY | 1 |
| Wu, HJ | 1 |
| Xue, X | 1 |
| Song, Y | 1 |
| Yu, X | 1 |
| Fan, Q | 1 |
| Tang, J | 1 |
| Chen, X | 1 |
| Sara, G | 1 |
| Baxter, C | 1 |
| Menendez, P | 1 |
| Lappin, J | 1 |
| Baig, AM | 1 |
| Voce, A | 1 |
| McKetin, R | 2 |
| Burns, R | 1 |
| Castle, D | 1 |
| Calabria, B | 1 |
| Snozek, CLH | 1 |
| Kaleta, EJ | 1 |
| Jannetto, PJ | 1 |
| Linkenmeyer, JJ | 1 |
| Harnish, TL | 1 |
| Stephen, J | 1 |
| Langman, LJ | 1 |
| Wang, R | 1 |
| Shen, YL | 1 |
| Hausknecht, KA | 1 |
| Chang, L | 1 |
| Haj-Dahmane, S | 1 |
| Vezina, P | 3 |
| Shen, RY | 1 |
| Miszkiel, J | 1 |
| Jastrzębska, J | 1 |
| Filip, M | 1 |
| Przegaliński, E | 1 |
| Lee, NK | 1 |
| Jenner, L | 1 |
| Harney, A | 1 |
| Cameron, J | 1 |
| Lam, L | 1 |
| Anand, S | 1 |
| Li, X | 1 |
| Tse, ML | 1 |
| Zhao, JX | 1 |
| Chan, EW | 1 |
| Hess, C | 1 |
| Losacker, M | 1 |
| Maas, A | 1 |
| Winkelman, TNA | 1 |
| Admon, LK | 1 |
| Jennings, L | 1 |
| Shippee, ND | 1 |
| Richardson, CR | 1 |
| Bart, G | 1 |
| Page, K | 1 |
| Carrico, AW | 1 |
| Stein, E | 1 |
| Evans, J | 1 |
| Sokunny, M | 1 |
| Maly, P | 1 |
| Sophal, C | 1 |
| Neak, Y | 1 |
| Ngak, S | 1 |
| McCulloch, C | 1 |
| Maher, L | 1 |
| Camacho, L | 1 |
| Silva, CS | 1 |
| Hanig, JP | 1 |
| Schleimer, RP | 1 |
| George, NI | 1 |
| Bowyer, JF | 1 |
| Maurer, LH | 1 |
| Stiebe, J | 1 |
| Chivaurah, BM | 1 |
| Lienert, D | 1 |
| Coates, D | 1 |
| Cuesta, S | 1 |
| Restrepo-Lozano, JM | 1 |
| Popescu, C | 1 |
| He, S | 1 |
| Reynolds, LM | 1 |
| Israel, S | 1 |
| Hernandez, G | 1 |
| Rais, R | 1 |
| Slusher, BS | 1 |
| Flores, C | 3 |
| Lappin, JM | 1 |
| Sara, GE | 1 |
| Jones, AW | 5 |
| Holmgren, A | 3 |
| Sembower, MA | 1 |
| Ertischek, MD | 1 |
| Buchholtz, C | 1 |
| Dasgupta, N | 1 |
| Schnoll, SH | 1 |
| Christensen, MR | 1 |
| Lesnikova, I | 1 |
| Madsen, LB | 1 |
| Rosendal, I | 1 |
| Banner, J | 1 |
| Heal, DJ | 1 |
| Smith, SL | 1 |
| Gosden, J | 1 |
| Nutt, DJ | 2 |
| Tournier, BB | 1 |
| Steimer, T | 1 |
| Millet, P | 1 |
| Moulin-Sallanon, M | 1 |
| Vallet, P | 1 |
| Ibañez, V | 1 |
| Ginovart, N | 1 |
| Suchankova, P | 1 |
| Jerlhag, E | 1 |
| Jayaram-Lindström, N | 3 |
| Nilsson, S | 1 |
| Toren, K | 1 |
| Rosengren, A | 1 |
| Engel, JA | 1 |
| Franck, J | 3 |
| Brensilver, M | 1 |
| Heinzerling, KG | 1 |
| Shoptaw, S | 1 |
| Blanckaert, P | 1 |
| van Amsterdam, J | 1 |
| Brunt, T | 1 |
| van den Berg, J | 1 |
| Van Durme, F | 1 |
| Maudens, K | 1 |
| van Bussel, J | 1 |
| Oliveira, LG | 1 |
| Endo, LG | 1 |
| Sinagawa, DM | 1 |
| Yonamine, M | 1 |
| Munoz, DR | 1 |
| Leyton, V | 1 |
| Schuster, AJ | 1 |
| Antoniazzi, CT | 1 |
| Łukasik-Głebocka, M | 1 |
| Sommerfeld, K | 1 |
| Tezyk, A | 1 |
| Zielińska-Psuja, B | 1 |
| Berg, T | 1 |
| Karlsen, M | 1 |
| Oiestad, AM | 1 |
| Johansen, JE | 1 |
| Liu, H | 1 |
| Strand, DH | 1 |
| Kameda, SR | 2 |
| Fukushiro, DF | 2 |
| Trombin, TF | 2 |
| Sanday, L | 1 |
| Wuo-Silva, R | 1 |
| Saito, LP | 1 |
| Tufik, S | 2 |
| D'Almeida, V | 2 |
| Frussa-Filho, R | 3 |
| Young, KA | 1 |
| Gobrogge, KL | 1 |
| Wang, H | 1 |
| Wang, Z | 2 |
| Du, J | 1 |
| Sun, H | 1 |
| Huang, D | 1 |
| Jiang, H | 1 |
| Zhong, N | 1 |
| Xu, D | 1 |
| Zhao, Y | 1 |
| Lin, S | 1 |
| Du, Z | 1 |
| Zhao, M | 1 |
| Hser, YI | 1 |
| Li, H | 1 |
| Scholl, JL | 2 |
| Tu, W | 2 |
| Hassell, JE | 1 |
| Watt, MJ | 2 |
| Forster, GL | 3 |
| Renner, KJ | 2 |
| Cook, A | 1 |
| Mears, M | 1 |
| Connolly, NP | 1 |
| Gomez-Serrano, M | 1 |
| Carson, DS | 1 |
| Horwitz, H | 1 |
| Skanning, P | 1 |
| Askaa, B | 1 |
| Jürgens, G | 1 |
| Shen, MY | 1 |
| Perreault, ML | 1 |
| Fan, T | 1 |
| George, SR | 1 |
| Shi, Y | 1 |
| Yu, Z | 1 |
| Bramness, JG | 4 |
| Reid, MJ | 1 |
| Solvik, KF | 1 |
| Vindenes, V | 2 |
| Rognli, EB | 1 |
| Medhus, SE | 1 |
| Lobmaier, PP | 1 |
| Larsen, GJ | 1 |
| Fulde, GW | 1 |
| Forster, SL | 1 |
| Godino, A | 1 |
| Jayanthi, S | 1 |
| Cadet, JL | 1 |
| Harro, J | 1 |
| Belujon, P | 1 |
| Jakobowski, NL | 1 |
| Dollish, HK | 1 |
| Grace, AA | 2 |
| Arndt, DL | 1 |
| Johns, KC | 1 |
| Dietz, ZK | 1 |
| Cain, ME | 1 |
| Andås, HT | 1 |
| Enger, A | 1 |
| Øiestad, ÅM | 1 |
| Christophersen, AS | 2 |
| Huestis, MA | 1 |
| Øiestad, EL | 1 |
| Meyer, MR | 1 |
| Vollerthun, T | 1 |
| Hasselbach, R | 1 |
| Brüning, CA | 1 |
| Courtney, KE | 1 |
| Ray, LA | 1 |
| Shakeri, J | 1 |
| Farnia, V | 1 |
| Karimi, AR | 1 |
| Tatari, F | 1 |
| Juibari, TA | 1 |
| Alikhani, M | 1 |
| Bajoghli, H | 1 |
| Holsboer-Trachsler, E | 1 |
| Brand, S | 1 |
| Kang, S | 1 |
| Paul, K | 1 |
| Hankosky, ER | 1 |
| Cox, CL | 1 |
| Smędra, A | 1 |
| Szustowski, S | 1 |
| Berent, J | 1 |
| Marszalek-Grabska, M | 1 |
| Gibula-Bruzda, E | 1 |
| Jenda, M | 1 |
| Gawel, K | 1 |
| Kotlinska, JH | 1 |
| Kueh, SA | 1 |
| Gabriel, RS | 1 |
| Lund, M | 1 |
| Sutton, T | 1 |
| Bradley, J | 1 |
| Kerr, AJ | 1 |
| Looi, JL | 1 |
| Harvanko, A | 1 |
| Martin, C | 1 |
| Lile, J | 1 |
| Kryscio, R | 1 |
| Kelly, TH | 2 |
| Kelly, PJ | 1 |
| Robinson, LD | 1 |
| Baker, AL | 1 |
| Deane, FP | 1 |
| Hudson, S | 1 |
| Keane, C | 1 |
| Mathews, IZ | 1 |
| Mills, RG | 1 |
| McCormick, CM | 1 |
| Kim, JY | 1 |
| Cheong, JC | 1 |
| Kim, MK | 1 |
| Lee, JI | 1 |
| In, MK | 1 |
| Pringle, RB | 1 |
| Mouw, NJ | 1 |
| Lukkes, JL | 1 |
| Crombag, HS | 1 |
| Ferrario, CR | 1 |
| Robinson, TE | 1 |
| Saylor, AJ | 1 |
| McGinty, JF | 3 |
| Eksborg, S | 1 |
| Rajs, J | 1 |
| Hammarberg, A | 2 |
| Beck, O | 1 |
| Chao, C | 1 |
| Jacobson, LP | 1 |
| Tashkin, D | 1 |
| Martínez-Maza, O | 1 |
| Roth, MD | 1 |
| Margolick, JB | 1 |
| Chmiel, JS | 1 |
| Holloway, MN | 1 |
| Zhang, ZF | 1 |
| Detels, R | 1 |
| Hara, T | 1 |
| Fujii, R | 1 |
| Ohno, S | 1 |
| Tomita, Y | 1 |
| Tsunoda, A | 1 |
| Maruki, C | 1 |
| Kurokawa, S | 1 |
| Harrison, SJ | 1 |
| Nobrega, JN | 1 |
| Lia, K | 1 |
| Spigset, O | 1 |
| Slørdal, L | 1 |
| Park, Y | 3 |
| Yang, W | 2 |
| Han, E | 4 |
| Choe, S | 2 |
| Lim, M | 2 |
| Chung, H | 4 |
| Degoulet, MF | 1 |
| Rostain, JC | 2 |
| David, HN | 2 |
| Abraini, JH | 2 |
| Ago, M | 1 |
| Ago, K | 1 |
| Ogata, M | 1 |
| Mao, LM | 1 |
| Chu, XP | 1 |
| Zhang, GC | 1 |
| Liu, XY | 1 |
| Yang, YJ | 1 |
| Haines, M | 1 |
| Papasian, CJ | 1 |
| Fibuch, EE | 1 |
| Buch, S | 1 |
| Chen, JG | 1 |
| Wang, JQ | 6 |
| Floresco, SB | 1 |
| Whelan, JM | 1 |
| Jemionek, JF | 1 |
| Addison, J | 1 |
| Past, MR | 1 |
| Haile, CN | 1 |
| Kosten, TR | 1 |
| Kosten, TA | 1 |
| Choi, H | 2 |
| Quarta, D | 1 |
| Valerio, E | 1 |
| Hutcheson, DM | 1 |
| Hedou, G | 1 |
| Heidbreder, C | 1 |
| Weyandt, LL | 1 |
| Janusis, G | 1 |
| Wilson, KG | 1 |
| Verdi, G | 1 |
| Paquin, G | 1 |
| Lopes, J | 1 |
| Varejao, M | 1 |
| Dussault, C | 1 |
| Gomółka, E | 1 |
| Król, A | 1 |
| Gawlikowski, T | 1 |
| Ferguson, SM | 1 |
| Sandygren, NA | 1 |
| Neumaier, JF | 1 |
| Kubakawa, T | 1 |
| Niimura, H | 1 |
| Elmer, GI | 1 |
| Pieper, JO | 1 |
| Hamilton, LR | 1 |
| Wise, RA | 1 |
| Liu, YP | 1 |
| Lin, PJ | 1 |
| Tseng, CJ | 1 |
| Wan, FJ | 1 |
| Tung, CS | 1 |
| Napper, LE | 1 |
| Fisher, DG | 1 |
| Johnson, ME | 1 |
| Wood, MM | 1 |
| Christine, CW | 2 |
| Garwood, ER | 2 |
| Schrock, LE | 1 |
| Austin, DE | 1 |
| McCulloch, CE | 2 |
| Schifano, F | 1 |
| Corkery, J | 1 |
| Naidoo, V | 1 |
| Oyefeso, A | 1 |
| Ghodse, H | 1 |
| Boileau, I | 1 |
| Houle, S | 1 |
| Rusjan, PM | 1 |
| Furukawa, Y | 2 |
| Wilkins, D | 1 |
| Tong, J | 1 |
| Selby, P | 1 |
| Wilson, AA | 1 |
| Kish, SJ | 2 |
| Gramage, E | 2 |
| Putelli, A | 1 |
| Polanco, MJ | 1 |
| González-Martín, C | 1 |
| Ezquerra, L | 1 |
| Alguacil, LF | 1 |
| Pérez-Pinera, P | 1 |
| Deuel, TF | 1 |
| Herradón, G | 2 |
| Röhrich, J | 1 |
| Zörntlein, S | 1 |
| Becker, J | 1 |
| Urban, R | 1 |
| Brunt, TM | 1 |
| van Laar, M | 1 |
| Niesink, RJ | 1 |
| van den Brink, W | 1 |
| Lawyer, G | 1 |
| Bjerkan, PS | 1 |
| Agartz, I | 1 |
| Velazquez-Sanchez, C | 1 |
| Ferragud, A | 1 |
| Renau-Piqueras, J | 1 |
| Canales, JJ | 2 |
| In, S | 2 |
| Chung, KH | 1 |
| Paz, MC | 1 |
| Assis, MA | 1 |
| Cabrera, RJ | 1 |
| Cancela, LM | 2 |
| Bregonzio, C | 1 |
| Broadbear, JH | 1 |
| Tunstall, B | 1 |
| Beringer, K | 1 |
| Rush, CR | 2 |
| Stoops, WW | 1 |
| Lile, JA | 1 |
| Glaser, PE | 1 |
| Hays, LR | 1 |
| Howard, J | 1 |
| Ali, H | 1 |
| Robins, L | 1 |
| Procópio-Souza, R | 1 |
| Patti, CL | 1 |
| Hollais, AW | 1 |
| Calzavara, MB | 1 |
| Abílio, VC | 1 |
| Ribeiro, RA | 1 |
| Degoulet, M | 1 |
| Ciccarone, D | 1 |
| Choodum, A | 1 |
| Daeid, NN | 1 |
| Yetnikoff, L | 1 |
| Almey, A | 1 |
| Arvanitogiannis, A | 2 |
| Marusich, JA | 1 |
| Darna, M | 1 |
| Charnigo, RJ | 1 |
| Dwoskin, LP | 1 |
| Bardo, MT | 2 |
| Muhammad, A | 1 |
| Kolb, B | 1 |
| Ladhani, NN | 1 |
| Shah, PS | 1 |
| Murphy, KE | 1 |
| Mohamed, WM | 1 |
| Ben Hamida, S | 1 |
| Cassel, JC | 1 |
| de Vasconcelos, AP | 1 |
| Jones, BC | 1 |
| Dueñas-Garcia, OF | 1 |
| Del Olmo, N | 1 |
| Fole, A | 1 |
| Martín, YB | 1 |
| Byrnes, JJ | 1 |
| Bridges, RS | 1 |
| Byrnes, EM | 1 |
| Drabek, M | 1 |
| Andysz, A | 1 |
| Khan, U | 1 |
| Nicell, JA | 1 |
| Carvalho, M | 1 |
| Carmo, H | 1 |
| Costa, VM | 1 |
| Capela, JP | 1 |
| Pontes, H | 1 |
| Remião, F | 1 |
| Carvalho, F | 1 |
| Bastos, Mde L | 1 |
| Ali, SF | 1 |
| MacLeod, RJ | 1 |
| Moores, ME | 1 |
| Beninger, RJ | 1 |
| Chen, SL | 1 |
| Lee, SY | 1 |
| Tao, PL | 1 |
| Chang, YH | 1 |
| Chen, SH | 1 |
| Chu, CH | 1 |
| Chen, PS | 1 |
| Lee, IH | 1 |
| Yeh, TL | 1 |
| Yang, YK | 1 |
| Hong, JS | 1 |
| Lu, RB | 1 |
| Nakamura, Y | 1 |
| Nakano, M | 1 |
| Takahashi, E | 1 |
| Suzuki, H | 1 |
| Hasuike, T | 1 |
| Akuzawa, H | 1 |
| Yuasa, H | 1 |
| Loweth, JA | 1 |
| Li, D | 1 |
| Cortright, JJ | 1 |
| Wilke, G | 1 |
| Jeyifous, O | 1 |
| Neve, RL | 2 |
| Bayer, KU | 1 |
| Che, Y | 1 |
| Cui, YH | 1 |
| Tan, H | 1 |
| Andreazza, AC | 1 |
| Young, LT | 1 |
| Wang, JF | 1 |
| Hsieh, HC | 1 |
| Li, HY | 1 |
| Lin, MY | 1 |
| Chiou, YF | 1 |
| Lin, SY | 1 |
| Wong, CH | 1 |
| Chen, JC | 1 |
| Vrang, N | 1 |
| Larsen, PJ | 1 |
| Kristensen, P | 1 |
| Shearer, J | 1 |
| Sherman, J | 1 |
| Wodak, A | 1 |
| van Beek, I | 1 |
| Holmes, PV | 1 |
| Masini, CV | 1 |
| Primeaux, SD | 1 |
| Garrett, JL | 1 |
| Zellner, A | 1 |
| Stogner, KS | 1 |
| Duncan, AA | 1 |
| Crystal, JD | 1 |
| Park, YH | 1 |
| Kantor, L | 1 |
| Wang, KK | 1 |
| Gnegy, ME | 2 |
| Huang, MK | 1 |
| Liu, C | 1 |
| Huang, SD | 1 |
| Choe, ES | 2 |
| Chung, KT | 1 |
| Mao, L | 2 |
| Lin, D | 1 |
| Bruijnzeel, AW | 1 |
| Schmidt, P | 1 |
| Markou, A | 4 |
| Ripley, TL | 1 |
| Dunworth, SJ | 1 |
| Stephens, DN | 1 |
| Ehrlich, ME | 1 |
| Sommer, J | 1 |
| Canas, E | 1 |
| Unterwald, EM | 1 |
| Vanderschuren, LJ | 2 |
| Schoffelmeer, AN | 2 |
| Van Leeuwen, SD | 1 |
| Hof, L | 1 |
| Jonker, AJ | 1 |
| Voorn, P | 1 |
| Gabbay, FH | 1 |
| Miquel, M | 1 |
| Font, L | 1 |
| Sanchis-Segura, C | 1 |
| Aragon, CM | 1 |
| Cryan, JF | 1 |
| Hoyer, D | 1 |
| BARUK, H | 1 |
| JOUBERT, P | 1 |
| ASKEVOLD, F | 1 |
| YOUNG, GG | 1 |
| SIMSON, CB | 1 |
| FROHMAN, CE | 1 |
| ABELY, P | 1 |
| BOBIN, P | 1 |
| GEIER, S | 1 |
| WALKER, PG | 1 |
| WILSON, CW | 1 |
| BECKETT, AH | 1 |
| ROWLAND, M | 1 |
| NEUENSCHWANDER, F | 1 |
| KILOH, LG | 1 |
| BRANDON, S | 1 |
| Avena, NM | 1 |
| Hoebel, BG | 1 |
| O'FLANAGAN, PM | 1 |
| TAYLOR, RB | 1 |
| KNAPP, PH | 1 |
| Parelkar, NK | 2 |
| Mohila, CA | 1 |
| Onn, SP | 2 |
| James, D | 1 |
| Davies, G | 1 |
| Willner, P | 1 |
| Chrostek Maj, J | 1 |
| Kroch, S | 1 |
| Kamenczak, A | 1 |
| Polewka, A | 1 |
| Szerszeń-Motyka, J | 1 |
| Corda, MG | 1 |
| Piras, G | 1 |
| Lecca, D | 1 |
| Fernández-Teruel, A | 1 |
| Driscoll, P | 1 |
| Giorgi, O | 1 |
| Härtel-Petri, R | 1 |
| Rodler, R | 1 |
| Schmeisser, U | 1 |
| Steinmann, J | 1 |
| Wolfersdorf, M | 1 |
| Oswald, LM | 2 |
| Wong, DF | 2 |
| McCaul, M | 1 |
| Zhou, Y | 2 |
| Kuwabara, H | 2 |
| Choi, L | 1 |
| Brasic, J | 2 |
| Wand, GS | 2 |
| Xu, W | 1 |
| Zhu, JP | 1 |
| Angulo, JA | 1 |
| Ventura, R | 1 |
| Puglisi-Allegra, S | 1 |
| Golub, M | 1 |
| Costa, L | 1 |
| Crofton, K | 1 |
| Frank, D | 1 |
| Fried, P | 1 |
| Gladen, B | 1 |
| Henderson, R | 1 |
| Liebelt, E | 1 |
| Lusskin, S | 1 |
| Marty, S | 1 |
| Rowland, A | 1 |
| Scialli, J | 1 |
| Vore, M | 1 |
| Klys, M | 1 |
| Konopka, T | 1 |
| Rojek, S | 1 |
| White, TL | 1 |
| Lott, DC | 1 |
| de Wit, H | 1 |
| Gustavsen, I | 2 |
| Mørland, J | 3 |
| Bray, GA | 1 |
| Karlsson, L | 1 |
| Holler, JM | 1 |
| Vorce, SP | 1 |
| Bosy, TZ | 2 |
| Jacobs, A | 1 |
| Shi, X | 1 |
| Schwendt, M | 1 |
| Gold, SJ | 1 |
| Peterson, JD | 1 |
| Wolf, ME | 3 |
| White, FJ | 1 |
| Russig, H | 1 |
| Pryce, CR | 1 |
| Feldon, J | 1 |
| Munro, CA | 1 |
| McCaul, ME | 1 |
| Kumar, A | 2 |
| Alexander, M | 1 |
| Ye, W | 1 |
| Bekele, W | 1 |
| Cheng, WC | 1 |
| Mok, VK | 1 |
| Chan, KK | 1 |
| Li, AF | 1 |
| Moy, SS | 1 |
| Perez, A | 1 |
| Koller, BH | 1 |
| Duncan, GE | 1 |
| Cunha-Oliveira, T | 1 |
| Rego, AC | 1 |
| Cardoso, SM | 1 |
| Borges, F | 1 |
| Swerdlow, RH | 1 |
| Macedo, T | 1 |
| de Oliveira, CR | 1 |
| Carta, M | 1 |
| Fadda, F | 1 |
| Stancampiano, R | 1 |
| Jacobs, W | 1 |
| Gilmour, S | 1 |
| Koch, I | 1 |
| Degenhardt, L | 1 |
| Day, C | 1 |
| Homayoun, H | 1 |
| Moghaddam, B | 1 |
| Vacca, G | 1 |
| Ahn, S | 1 |
| Phillips, AG | 1 |
| O'Neil, ML | 1 |
| Kuczenski, R | 2 |
| Segal, DS | 2 |
| Cho, AK | 2 |
| Lacan, G | 1 |
| Melega, WP | 2 |
| Green, TA | 1 |
| Alibhai, IN | 1 |
| Hommel, JD | 1 |
| DiLeone, RJ | 1 |
| Theobald, DE | 1 |
| Nestler, EJ | 1 |
| Rünkorg, K | 1 |
| Värv, S | 1 |
| Matsui, T | 1 |
| Kõks, S | 1 |
| Vasar, E | 1 |
| Kumihashi, M | 1 |
| Ameno, K | 1 |
| Shibayama, T | 1 |
| Suga, K | 1 |
| Miyauchi, H | 1 |
| Jamal, M | 1 |
| Uekita, I | 1 |
| Ijiri, I | 1 |
| Nishida, M | 1 |
| Yashiki, M | 1 |
| Namera, A | 1 |
| Kimura, K | 1 |
| Robbins, G | 1 |
| Martin, CA | 1 |
| Fillmore, MT | 1 |
| Lane, SD | 1 |
| Harrington, NG | 1 |
| Yin, HS | 2 |
| Chen, K | 1 |
| Kalpana, S | 1 |
| Shih, JC | 1 |
| Stairs, DJ | 1 |
| Klein, ED | 1 |
| Giordano, TP | 1 |
| Satpute, SS | 1 |
| Striessnig, J | 1 |
| Kosofsky, BE | 1 |
| Rajadhyaksha, AM | 1 |
| Harrison, G | 1 |
| Dilley, JW | 1 |
| Loeb, L | 1 |
| Nelson, K | 1 |
| Ukairo, OT | 1 |
| Ramanujapuram, S | 1 |
| Surratt, CK | 1 |
| Tiihonen, J | 1 |
| Kuoppasalmi, K | 1 |
| Föhr, J | 1 |
| Tuomola, P | 1 |
| Kuikanmäki, O | 1 |
| Vorma, H | 1 |
| Sokero, P | 1 |
| Haukka, J | 1 |
| Meririnne, E | 1 |
| Costa, FG | 1 |
| Canteras, NS | 1 |
| Valera, AG | 1 |
| Felicio, LF | 1 |
| Zebis, LP | 1 |
| Christensen, TD | 1 |
| Bøttcher, M | 1 |
| Eiskjaer, HE | 1 |
| Lorenzen, AG | 1 |
| Ilkjaer, LB | 1 |
| Baandrup, U | 1 |
| Janus, T | 1 |
| Aragona, BJ | 1 |
| Detwiler, JM | 1 |
| Valvassori, SS | 1 |
| Frey, BN | 1 |
| Martins, MR | 1 |
| Réus, GZ | 1 |
| Schimidtz, F | 1 |
| Inácio, CG | 1 |
| Kapczinski, F | 1 |
| Quevedo, J | 1 |
| Eyerman, DJ | 1 |
| Yamamoto, BK | 1 |
| Yates, JW | 1 |
| Meij, JT | 1 |
| Sullivan, JR | 1 |
| Richtand, NM | 1 |
| Yu, L | 1 |
| Shahbazi, M | 1 |
| Moffett, AM | 1 |
| Williams, BF | 1 |
| Frantz, KJ | 1 |
| Dupont, RL | 1 |
| Bucher, RH | 1 |
| Wilford, BB | 1 |
| Coleman, JJ | 1 |
| Movahed, MR | 1 |
| Mostafizi, K | 1 |
| Phillips, TJ | 1 |
| Kamens, HM | 1 |
| Wheeler, JM | 1 |
| Ersche, KD | 1 |
| Roiser, JP | 1 |
| Robbins, TW | 1 |
| Sahakian, BJ | 1 |
| Cox, S | 1 |
| Posner, SF | 1 |
| Kourtis, AP | 1 |
| Jamieson, DJ | 1 |
| Skurtveit, S | 1 |
| Kugelberg, FC | 1 |
| Rawls, SM | 1 |
| Cavallo, F | 1 |
| Capasso, A | 1 |
| Ding, Z | 1 |
| Raffa, RB | 1 |
| Caprioli, D | 1 |
| Celentano, M | 1 |
| Paolone, G | 1 |
| Lucantonio, F | 1 |
| Bari, A | 1 |
| Nencini, P | 1 |
| Badiani, A | 1 |
| Smith-Kielland, A | 2 |
| Skuterud, B | 1 |
| Czerwinski, WP | 1 |
| Musshoff, F | 1 |
| Kraemer, T | 1 |
| Burchett, SA | 1 |
| Bannon, MJ | 1 |
| Granneman, JG | 1 |
| al-Dirbashi, O | 1 |
| Kuroda, N | 1 |
| Inuduka, S | 1 |
| Menichini, F | 1 |
| Nakashima, K | 1 |
| Christensen, HR | 2 |
| Hedetoft, C | 1 |
| Williams, K | 1 |
| Argyropoulos, S | 1 |
| Tzschentke, TM | 1 |
| Schmidt, WJ | 1 |
| Michelhaugh, SK | 1 |
| Stewart, J | 1 |
| Jones, S | 1 |
| Kornblum, JL | 1 |
| Kauer, JA | 1 |
| Heidenreich, BA | 1 |
| Rebec, GV | 1 |
| Sullivan, J | 1 |
| Amir, S | 1 |
| Zhang, K | 1 |
| Tarazi, FI | 1 |
| Campbell, A | 1 |
| Baldessarini, RJ | 1 |
| Paterson, NE | 1 |
| Myers, C | 1 |
| Kalasinsky, KS | 1 |
| Schmunk, GA | 1 |
| Reiber, G | 1 |
| Anthony, RM | 1 |
| Guttman, M | 1 |
| Yu, MF | 1 |
| Fu, WM | 1 |
| Harrison, AA | 1 |
| Liem, YT | 1 |
| Basso, AM | 1 |
| Martijena, ID | 1 |
| Capriles, NR | 1 |
| Molina, VA | 1 |
| Giorgetti, M | 2 |
| Hotsenpiller, G | 2 |
| Ward, P | 1 |
| Teppen, T | 1 |
| Andersen, SL | 1 |
| LeBlanc, CJ | 1 |
| Lyss, PJ | 1 |
| Kuronen, M | 1 |
| Välimäki, TM | 1 |
| Koponen, H | 1 |
| Wyvell, CL | 1 |
| Berridge, KC | 1 |
| Froestl, W | 1 |
| De Vries, TJ | 1 |
| Wardeh, G | 1 |
| van de Ven, HW | 1 |
| Lorrain, DS | 1 |
| Arnold, GM | 1 |
| Austin, JD | 1 |
| Suto, N | 1 |
| Adriani, W | 1 |
| Laviola, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Opioid Use Disorder in the Emergency Department: Clinical Trials Network-0069[NCT03023930] | 1,731 participants (Actual) | Interventional | 2017-04-03 | Completed | |||
| A Multi-Center, Open Label, Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder[NCT03337646] | Phase 4 | 48 participants (Actual) | Interventional | 2018-09-26 | Active, not recruiting | ||
| A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans[NCT03331978] | 306 participants (Actual) | Interventional | 2018-01-23 | Completed | |||
| Pomegranate Juice Consumption by Patients Under Medication for Addiction Treatment as a Regulator of Craving and Blood Redox Status: The Study Protocol of a Randomized Control Trial (the NUTRIDOPE Study)[NCT05861544] | 58 participants (Anticipated) | Interventional | 2023-03-23 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary effectiveness outcome is defined as the rates of patient engagement in formal addiction treatment on the 30th day post enrollment. (NCT03023930)
Timeframe: 30 Days Post Enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Baseline Evaluation Period Cohort | 40 |
| IF Evaluation Period Cohort | 59 |
The primary implementation outcome will be evaluated assessing the rate of ED-initiated BUP therapy with referral for ongoing MAT (NCT03023930)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Baseline Evaluation Period Cohort | 2 |
| IF Evaluation Period Cohort | 53 |
Percentage of doses taken of those prescribed from electronic monitoring. Here we present all data collected at all time points used in analysis. Evaluation of intervention efficacy was performed with repeated measures regression using continuous adherence measurements at all 6 months post-intervention (7th through 12th month post-baseline) and was restricted to those with adherence data at baseline. (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7, 8, 9, 10, 11, and 12 months post-baseline
| Intervention | percentage of doses taken (Mean) | |||||
|---|---|---|---|---|---|---|
| 7 months post-baseline | 8 months post-baseline | 9 months post-baseline | 10 months post-baseline | 11 months post-baseline | 12 months post-baseline | |
| Control - No Treatment Education | 70.95 | 70.02 | 64.62 | 71.08 | 63.76 | 70.46 |
| Rise - Treatment Education | 68.80 | 72.76 | 72.09 | 71.27 | 69.87 | 70.32 |
Number of Participants who Reported Taking Greater Than or Equal to 75% of Prescribed Dosage, based on electronic monitoring. Here we present all data collected at all time points used in analysis. Evaluation of intervention efficacy was performed with repeated measures regression using adherence measurements at all 6 months post-intervention (7th through 12th month post-baseline) and was restricted to those with adherence data at baseline. (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7, 8, 9, 10, 11, and 12 months post-baseline
| Intervention | Participants (Count of Participants) | |||||
|---|---|---|---|---|---|---|
| 7 months post-baseline | 8 months post-baseline | 9 months post-baseline | 10 months post-baseline | 11 months post-baseline | 12 months post-baseline | |
| Control - No Treatment Education | 43 | 40 | 38 | 32 | 29 | 28 |
| Rise - Treatment Education | 45 | 44 | 43 | 42 | 40 | 37 |
"Measure is count of participants who slightly agree or strongly agree with either Most people with AIDS are responsible for having their illness or A person with AIDS must have done something wrong and deserves to be punished." (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7 and 12 months post-baseline
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| 7 months post-baseline | 12 months post-baseline | |
| Control - No Treatment Education | 29 | 26 |
| Rise - Treatment Education | 25 | 15 |
Outcome is mean agreement with 9 HIV-related conspiracy beliefs, each measured on a 5-point scale from 1=Strongly Disagree to 5=Strongly Agree. (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7 and 12 months post-baseline
| Intervention | score on a scale (Mean) | |
|---|---|---|
| 7 months post-baseline | 12 months post-baseline | |
| Control - No Treatment Education | 2.65 | 2.56 |
| Rise - Treatment Education | 2.62 | 2.41 |
Viral load undetectable per venipuncture or medical records (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7 and 12 months post-baseline. For 7M, medical records were used if within 90 days of survey completion; for 13 months, medical records were used if within 90 days before or 180 days after survey
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| 7 month post-baseline | 12 month post-baseline | |
| Control - No Treatment Education | 60 | 56 |
| Rise - Treatment Education | 45 | 50 |
33 reviews available for amphetamine and Amphetamine Abuse
| Article | Year |
|---|---|
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.
Topics: Amphetamine; Amphetamine-Related Disorders; Analgesics; Animals; Cannabinoid Receptor Agonists; Cann | 2022 |
Methamphetamine, amphetamine, and aggression in humans: A systematic review of drug administration studies.
Topics: Aggression; Amphetamine; Amphetamine-Related Disorders; Humans; Methamphetamine | 2022 |
Does chronic use of amphetamine-type stimulants impair interference control? - A meta-analysis.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Dopamine; Huma | 2023 |
Methamphetamine: Mechanism of Action and Chinese Herbal Medicine Treatment for Its Addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Behavior, Addictive; Drugs, Chinese Herbal; Humans; Meth | 2023 |
Mucocutaneous alterations and complications in amphetamine abusers: a narrative review.
Topics: Administration, Cutaneous; Amphetamine; Amphetamine-Related Disorders; Humans; Methamphetamine; Skin | 2023 |
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Humans; Meth | 2020 |
AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.
Topics: Adolescent; Adolescent Behavior; Adolescent Development; Adult; Age Factors; Amphetamine; Amphetamin | 2020 |
Pharmacotherapy for amphetamine dependence: A systematic review.
Topics: Amphetamine; Amphetamine-Related Disorders; Dextroamphetamine; Humans; Medication Adherence; Methylp | 2018 |
Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials.
Topics: Amphetamine; Amphetamine-Related Disorders; Humans; Methamphetamine; Naltrexone; Narcotic Antagonist | 2019 |
Psychostimulant use and the brain.
Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocai | 2019 |
Amphetamine, past and present--a pharmacological and clinical perspective.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Animals; Attention Deficit Disorder w | 2013 |
Pharmacotherapy of amphetamine-type stimulant dependence: an update.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Bupropion; Central Nervous System Stimulants; H | 2013 |
[Amphetamine abuse and drug interactions].
Topics: Amphetamine; Amphetamine-Related Disorders; Antidepressive Agents; Central Nervous System Stimulants | 2014 |
The impact of amphetamine-type stimulants on emergency services.
Topics: Acute Disease; Aggression; Amphetamine; Amphetamine-Related Disorders; Anxiety; Central Nervous Syst | 2015 |
Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
Topics: Acetylation; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Central N | 2015 |
Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine.
Topics: Aggression; Amphetamine; Amphetamine-Related Disorders; Brain; Cognition Disorders; Humans; Mental D | 2015 |
Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Humans; Neur | 2016 |
Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Cocaine-Related Disorders; Disulfiram; Dopamine Uptake I | 2009 |
[Psychiatric care for patients with addiction of amphetamine, CNS stimulant].
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Crime; Female; Haloperidol; | 2009 |
Alcohol, cannabis and amphetamine-type stimulants use among young Pacific Islanders.
Topics: Adolescent; Alcohol Drinking; Amphetamine; Amphetamine-Related Disorders; Cannabis; Child; Female; H | 2011 |
Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine; Cocaine-Rela | 2011 |
Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Female; Humans; Infant, Low Birth Weight; Infant, | 2011 |
MDMA: interactions with other psychoactive drugs.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Caffeine; Cannabis; Central Nervous System Depr | 2011 |
[Effects of marijuana and amphetamine (and its derivatives on driving performance based on the driving simulator studies].
Topics: Accidents, Traffic; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Cannabis; Centra | 2011 |
Toxicity of amphetamines: an update.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Chemical and | 2012 |
Substitution therapy for amphetamine users.
Topics: Amphetamine; Amphetamine-Related Disorders; Dextroamphetamine; Feasibility Studies; Humans | 2002 |
Stimulant-induced adaptations in neostriatal matrix and striosome systems: transiting from instrumental responding to habitual behavior in drug addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Arousal; Basal Ganglia; Central Nervous System | 2005 |
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine.
Topics: Age Factors; Amphetamine; Amphetamine-Related Disorders; Animals; Child; Environmental Exposure; Fem | 2005 |
Behavioral genetic contributions to the study of addiction-related amphetamine effects.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Addictive; Behavior, Animal; Chromoso | 2008 |
Amphetamine-related disorders.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; History, 20th Century; Humans; Sympathomimetics | 1998 |
[Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine; Cocaine-Rela | 1999 |
Time acts as a conditioned stimulus to control behavioral sensitization to amphetamine in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Circadian Rhythm; Conditionin | 2000 |
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Disease Models, Animal; Humans; Methamphetamine | 2001 |
12 trials available for amphetamine and Amphetamine Abuse
| Article | Year |
|---|---|
Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Benzodiazepines; Brief Psyc | 2018 |
Cluster randomized stepped-wedge trial of a multi-level HIV prevention intervention to decrease amphetamine-type stimulants and sexual risk in Cambodian female entertainment and sex workers.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Asian People; Central Nervous System Stimulants; | 2019 |
Clinical Characteristics and Outcomes of Patients with Amphetamine-Associated Cardiomyopathy in South Auckland, New Zealand.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Cardiomyopathies; Female; Humans; Male; Middle Ag | 2016 |
Individual differences in the reinforcing and subjective effects of d-amphetamine: Dimensions of impulsivity.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Double-Blind Method; Female; Humans; Impulsive Be | 2016 |
Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Double-Blind Method; Female; Humans; Male; Middle | 2008 |
Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
Topics: Administration, Intranasal; Adult; Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; | 2011 |
Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Analgesics, Opioid; Central Nervous System Stimul | 2012 |
Variations in affect following amphetamine and placebo: markers of stimulant drug preference.
Topics: Adult; Affect; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognit | 2003 |
Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine.
Topics: Adolescent; Adult; Affect; Amphetamine; Amphetamine-Related Disorders; Carbon Radioisotopes; Causali | 2005 |
Sex differences in striatal dopamine release in healthy adults.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Basal Ganglia; Brain Mapping; Carbon Radioisotope | 2006 |
Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Attention; Behavior, Addict | 2006 |
A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Aripiprazole; Female; Humans; Male; Methylphenida | 2007 |
229 other studies available for amphetamine and Amphetamine Abuse
| Article | Year |
|---|---|
Did the under-reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased?
Topics: Aged; Amphetamine; Amphetamine-Related Disorders; Australia; Cross-Sectional Studies; Female; Humans | 2022 |
Evidence for gender differences in the Amphetamine/Methamphetamine ratio in the hair of subjects undergoing Fitness-to-Drive testing.
Topics: Amphetamine; Amphetamine-Related Disorders; Female; Hair; Humans; Methamphetamine; Retrospective Stu | 2022 |
Impact of two different types of exercise training on AMPH addiction: Role of hippocampal neurotrophins.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Hippocampus; | 2022 |
Sleep Deprivation & Amphetamine Induced Psychosis.
Topics: Amphetamine; Amphetamine-Related Disorders; Humans; Psychoses, Substance-Induced; Psychotic Disorder | 2022 |
Applying computerized adaptive testing to the Desires for Speed Questionnaire in the Chinese population: A simulation study.
Topics: Amphetamine; Amphetamine-Related Disorders; China; Computer Simulation; Computerized Adaptive Testin | 2023 |
Physical Exercise Promotes Beneficial Changes on Neurotrophic Factors in Mesolimbic Brain Areas After AMPH Relapse: Involvement of the Endogenous Opioid System.
Topics: Amphetamine; Amphetamine-Related Disorders; Analgesics, Opioid; Animals; Brain; Male; Naloxone; Nerv | 2023 |
Interaction of stress and stimulants in female rats: Role of chronic stress on later reactivity to methamphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Chronic Dise | 2019 |
An epidemic amphetamine problem: commentary on treatment of amphetamine abuse/use disorder.
Topics: Amphetamine; Amphetamine-Related Disorders; Epidemics; Humans | 2020 |
The colours of amphetamine-induced cardiomyopathy.
Topics: Administration, Inhalation; Adult; Amphetamine; Amphetamine-Related Disorders; Cardiomyopathies; Car | 2020 |
Amphetamine and methamphetamine poisonings attended in hospital emergency departments: clinical features and the usefulness of laboratory confirmation.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Emergency Service, Hospital; Female; Hospitals; H | 2020 |
Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cr | 2020 |
Amphetamine-type stimulant use among patients admitted to the emergency department behavioural assessment unit: Screening and referral outcomes.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Australia; Emergency Service, Hospital; Humans; I | 2020 |
Involvement of the endogenous opioid system in the beneficial influence of physical exercise on amphetamine-induced addiction parameters.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning | 2020 |
Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Chromatography | 2020 |
Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Case-Control Studies; Central Nervous System Stim | 2020 |
Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Cannabidiol; Central Nervous System Stim | 2021 |
The Abuse Characteristics of Amphetamine-Type Stimulants in Patients Receiving Methadone Maintenance Treatment and Buprenorphine Maintenance Treatment.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Buprenorphine; Female; Humans; Male; Methadone; R | 2021 |
A Longitudinal Study of Self-Reported Psychopathology in Beginning Ecstasy and Amphetamine Users: A Third Follow-up Evaluation.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Female; Follow-Up Studies; Hallucinog | 2017 |
Could Modafinil Prevent Psychostimulant Addiction? An Experimental Study in Rats.
Topics: Age Factors; Amphetamine; Amphetamine-Related Disorders; Animals; Antioxidants; Behavior, Animal; Be | 2017 |
Influence of physical activity on addiction parameters of rats exposed to amphetamine which were previously supplemented with hydrogenated vegetable fat.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain; Cerebral Cort | 2017 |
Reduction in endogenous cardiac steroids protects the brain from oxidative stress in a mouse model of mania induced by amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Antibodies; Antioxidants; Bipolar Disorder; Bra | 2018 |
Chronic amphetamine treatment affects collicular-dependent behaviour.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Attention; Central Nervous System Stimulants; M | 2018 |
Disappearance of R/S-methamphetamine and R/S-amphetamine from human scalp hair after discontinuation of methamphetamine abuse.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Chromatography, Liquid; Female; Hair; Half-Life; | 2018 |
[Identification of Methamphetamine Abuse and Selegiline Use： Chiral Analysis of Methamphetamine and Amphetamine in Urine].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Chromatography, Liqui | 2017 |
Amphetamine availability predicts amphetamine-related mental health admissions: A time series analysis.
Topics: Amphetamine; Amphetamine-Related Disorders; Australia; Crime; Hospitalization; Humans; Psychoses, Su | 2018 |
DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Brain; Cognition; Drug Tolerance; Humans; | 2018 |
The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Amphetamine; Amphetamine-Related Disorders; Austr | 2018 |
False-positive amphetamine results on several drug screening platforms due to mexiletine.
Topics: Amphetamine; Amphetamine-Related Disorders; False Positive Reactions; Female; Humans; Immunoassay; M | 2018 |
Prenatal ethanol exposure increases risk of psychostimulant addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Addictive; Central Nervous System Sti | 2019 |
Amphetamine Self-Administration and Its Extinction Alter the 5-HT
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Disea | 2019 |
Chromatographic separation of R-(-)/S-(+)-enantiomers of amphetamine and methamphetamine: differentiation between single methamphetamine consumption and co-consumption with amphetamine using enantioselective quantitative LC-MS/MS analysis.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Chromatography, Liqui | 2019 |
Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States.
Topics: Adolescent; Adult; Aged; Amphetamine; Amphetamine-Related Disorders; Cross-Sectional Studies; Drug-R | 2018 |
Modafinil reduces amphetamine preference and prevents anxiety-like symptoms during drug withdrawal in young rats: Involvement of dopaminergic targets in VTA and striatum.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Cor | 2019 |
Identification of whole blood mRNA and microRNA biomarkers of tissue damage and immune function resulting from amphetamine exposure or heat stroke in adult male rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Biomarkers; Fever; Heat Stroke; Male; MicroRNAs | 2019 |
Omega-3 decreases D1 and D2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Conditioning, Classical; Fatty Acids; Fatty Aci | 2019 |
Amphetamine-type-substance-related presentations to the Emergency Department Mental Health Team of a local health district in Australia.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Emergency Service, Hospital; Female; | 2019 |
DCC-related developmental effects of abused- versus therapeutic-like amphetamine doses in adolescence.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimul | 2020 |
Amphetamine abuse in Sweden: subject demographics, changes in blood concentrations over time, and the types of coingested substances.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Cause of Death; Databases, Fa | 2013 |
Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Attention Deficit Disorder with Hyper | 2013 |
Drug-induced bilateral ischemic infarction in an amphetamine addict.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Autopsy; Brain; Brain Infarction; Cause of Death; | 2013 |
Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Benzamides; Benzopyrans; | 2013 |
Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence.
Topics: Adult; Alleles; Amphetamine; Amphetamine-Related Disorders; Case-Control Studies; Female; Gene Frequ | 2013 |
4-Methyl-amphetamine: a health threat for recreational amphetamine users.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dopamine Agents; Drug Users; Humans; Metha | 2013 |
[Persistent amphetamine consumption by truck drivers in São Paulo State, Brazil, despite the ban on production, prescription, and use].
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Brazil; Humans; Illicit Drugs | 2013 |
Exercise modifies amphetamine relapse: behavioral and oxidative markers in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Biomarkers; Catalase; Conditioning, Ps | 2014 |
[Acute poisoning with weight-loss dietary supplement falsely suggesting the use of amphetamine].
Topics: Adolescent; Amphetamine; Amphetamine-Related Disorders; Anti-Obesity Agents; Diagnosis, Differential | 2013 |
Evaluation of ¹³C- and ²H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Carbon Isotopes; Chromatography, Liquid; D | 2014 |
The effects of paradoxical sleep deprivation on amphetamine-induced behavioral sensitization in adult and adolescent mice.
Topics: Age Factors; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous | 2014 |
Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Arvicolinae; Dopamine; Female; Male; Microdialy | 2014 |
Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Behavior, Addictive; Central Nervous | 2014 |
Serotonergic responses to stress are enhanced in the central amygdala and inhibited in the ventral hippocampus during amphetamine withdrawal.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Amygdaloid Nucleus; Central Nervous Sys | 2014 |
Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervo | 2014 |
D4 dopamine receptor-specific antagonist improves reversal learning impairment in amphetamine-treated male rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Attention; Behavior, Animal; Central Nervous Sy | 2014 |
Oxytocin treatment for amphetamine-induced social impairments.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Dopamine; Female; Male; Nucleus Accumbens; Oxyt | 2014 |
The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Amphetamine-Related Disorde | 2015 |
Chiral separation and determination of R/S-methamphetamine and its metabolite R/S-amphetamine in urine using LC-MS/MS.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Chromatography, Liqui | 2015 |
Recent trends in the availability and use of amphetamine and methamphetamine in Norway.
Topics: Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Autopsy; Central Nervous System Stim | 2015 |
[Amphetamine-induced psychosis or schizophrenia?].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Methamphetami | 2015 |
[Re: Amphetamine-induced psychosis or schizophrenia?].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Psychoses, Su | 2015 |
Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine.
Topics: Action Potentials; Amphetamine; Amphetamine-Related Disorders; Animals; Basolateral Nuclear Complex; | 2016 |
Environmental condition alters amphetamine self-administration: role of the MGluR₅ receptor and schedule of reinforcement.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Environment; | 2015 |
Extended Detection of Amphetamine and Methamphetamine in Oral Fluid.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Dose-Response Relationship, Drug; Female; Humans; | 2016 |
Prevalence and distribution patterns of amphetamine and methamphetamine consumption in a federal state in southwestern Germany using wastewater analysis.
Topics: Amphetamine; Amphetamine-Related Disorders; Cross-Sectional Studies; Geography, Medical; Germany; Me | 2015 |
m-Trifluoromethyl-diphenyldiselenide as a pharmacological tool to treat preference symptoms related to AMPH-induced dependence in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Association Learning; Choice Behavior; Conditio | 2016 |
The prevalence and clinical features of amphetamine-induced obsessive compulsive disorder.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectiona | 2016 |
D1 receptor-mediated inhibition of medial prefrontal cortex neurons is disrupted in adult rats exposed to amphetamine in adolescence.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Amphetamine-Related Disorde | 2016 |
Amphetamine-related myocardial infarction in a 42-year old man.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Fatal Outcome; Humans; Illicit Drugs; Male; Myoca | 2015 |
Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Antidepressive Agents; Central Nervous System S | 2016 |
Polysubstance use in treatment seekers who inject amphetamine: Drug use profiles, injecting practices and quality of life.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Comorbidity; F | 2017 |
Chronic social stress in adolescence influenced both amphetamine conditioned place preference and locomotor sensitization.
Topics: Age Factors; Amphetamine; Amphetamine-Related Disorders; Animals; Appetitive Behavior; Central Nervo | 2008 |
Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dronabinol; | 2008 |
Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus.
Topics: Adrenal Cortex Hormones; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety Disorders; Cen | 2008 |
The rate of intravenous cocaine or amphetamine delivery does not influence drug-taking and drug-seeking behavior in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Body Temperature; Cocaine; Cocaine-Related Diso | 2008 |
Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Amphetamine-Related Disorders; Animals; Brain Chemistry; | 2008 |
Causes and manners of death among users of heroin, methadone, amphetamine, and cannabis in relation to postmortem chemical tests for illegal drugs.
Topics: Adolescent; Adult; Aged; Amphetamine; Amphetamine-Related Disorders; Cause of Death; Diagnosis; Fema | 2008 |
Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Cohort Studies; HIV Infections; Humans; Illicit D | 2009 |
[Case of intracerebral hemorrhage due to amphetamine abuse].
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Cerebral Angiography; Cerebral Hemorrhage; Female | 2008 |
Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.
Topics: Alcoholic Intoxication; Amphetamine; Amphetamine-Related Disorders; Animals; Autoradiography; Behavi | 2009 |
[Driving under the influence of amphetamine and metamphetamine].
Topics: Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Central Nervous System Stimulants; D | 2009 |
Estimation of the measurement uncertainty of methamphetamine and amphetamine in hair analysis.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Forensic Toxicology; | 2009 |
Repeated administration of amphetamine induces a shift of the prefrontal cortex and basolateral amygdala motor function.
Topics: Amphetamine; Amphetamine-Related Disorders; Amygdala; Analysis of Variance; Anesthetics, Local; Anim | 2009 |
Determination of methamphetamine in sudden death of a traffic accident inpatient by blood and hair analyses.
Topics: Accidents, Traffic; Adult; Amphetamine; Amphetamine-Related Disorders; Brain Edema; Central Nervous | 2009 |
Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine.
Topics: Adaptation, Physiological; Adrenergic Uptake Inhibitors; Amphetamine; Amphetamine-Related Disorders; | 2009 |
Perturbations in different forms of cost/benefit decision making induced by repeated amphetamine exposure.
Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Behavior, Animal; Central | 2009 |
Low concentrations of methamphetamine detectable in urine in the presence of high concentrations of amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Forensic Toxicology; | 2009 |
Distribution of methamphetamine and amphetamine in drug abusers' head hair.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Forensic Toxicology; | 2009 |
The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benzoxazoles; Dopamine; Dopamine Uptake Inhibit | 2010 |
Nonmedical prescription stimulant use among a sample of college students: relationship with psychological variables.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Female; Health Behavior; He | 2009 |
[Amphetamine and its analogues determination in urine from patients hospitalized in the Department of Toxicology Jagiellonian University Collegium Medicum in Krakow].
Topics: Amphetamine; Amphetamine-Related Disorders; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamph | 2009 |
Pairing mild stress with increased serotonin-1B receptor expression in the nucleus accumbens increases susceptibility to amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Behavior, Animal; Central | 2009 |
Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration.
Topics: Amphetamine; Amphetamine-Related Disorders; Analgesics, Opioid; Animals; Behavior, Addictive; Behavi | 2010 |
Role of dopaminergic DAD1 and DAD2 receptors in the sensitization of amphetamine-suppressed schedule-induced polydipsia in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Benzazepines; Dopamine Agents | 2009 |
The reliability and validity of drug users' self reports of amphetamine use among primarily heroin and cocaine users.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphetamine; Amphetamine-Related Disorders; Cocaine-Rela | 2010 |
Parkinsonism in patients with a history of amphetamine exposure.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Case-Control Studies; Dopamine Agents; Environmen | 2010 |
Overview of amphetamine-type stimulant mortality data--UK, 1997-2007.
Topics: Adolescent; Adult; Age Factors; Aged; Amphetamine; Amphetamine-Related Disorders; Central Nervous Sy | 2010 |
Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans.
Topics: Administration, Oral; Adult; Amphetamine; Amphetamine-Related Disorders; Binding, Competitive; Centr | 2010 |
The neurotrophic factor pleiotrophin modulates amphetamine-seeking behaviour and amphetamine-induced neurotoxic effects: evidence from pleiotrophin knockout mice.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Carrier Proteins; Cell Survival; Conditioning, | 2010 |
Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dronabinol; False Negative Reactions; Fals | 2010 |
The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Cocaine; Cocaine-Related Disorders; Commerce; Fem | 2010 |
Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.
Topics: Adult; Alcoholism; Amphetamine; Amphetamine-Related Disorders; Brain Injuries; Central Nervous Syste | 2010 |
Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Benztropine; Conditioning, Ps | 2011 |
Analysis of pubic hair as an alternative specimen to scalp hair: a contamination issue.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Forensic Toxicology; | 2011 |
The AT₁ angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol.
Topics: Amphetamine; Amphetamine-Related Disorders; Angiotensin II Type 1 Receptor Blockers; Animals; Behavi | 2011 |
Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat.
Topics: Adrenergic Uptake Inhibitors; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; | 2011 |
Adolescent mice are more vulnerable than adults to single injection-induced behavioral sensitization to amphetamine.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Addictive; Behavio | 2011 |
Short-term development of behavioral sensitization to amphetamine requires N-methyl-D-aspartate- and nicotinic-dependent mechanisms in the nucleus accumbens.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Excitatory A | 2013 |
Digital image-based colourimetric [corrected] tests for amphetamine and methylamphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Calibration; Central Nervous System Stimulants; Colorime | 2011 |
Abolition of the behavioral phenotype of adult netrin-1 receptor deficient mice by exposure to amphetamine during the juvenile period.
Topics: Aging; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Blotting, Western; DCC | 2011 |
A multivariate assessment of individual differences in sensation seeking and impulsivity as predictors of amphetamine self-administration and prefrontal dopamine function in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Avoidance Learning; Behavior, Animal; Central N | 2011 |
Prenatal tactile stimulation attenuates drug-induced behavioral sensitization, modifies behavior, and alters brain architecture.
Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Animals, Newborn; Behavio | 2011 |
False-positive amphetamine toxicology screen results in three pregnant women using labetalol.
Topics: Amphetamine; Amphetamine-Related Disorders; Antihypertensive Agents; False Positive Reactions; Femal | 2011 |
Periadolescent amphetamine treatment causes transient cognitive disruptions and long-term changes in hippocampal LTP depending on the endogenous expression of pleiotrophin.
Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Avoidance Learning; CA1 R | 2013 |
Amphetamine sensitization in reproductively experienced female rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Dopamine Uptake Inhibitors; Dose-Response Relat | 2011 |
Sewer epidemiology mass balances for assessing the illicit use of methamphetamine, amphetamine and tetrahydrocannabinol.
Topics: Amphetamine; Amphetamine-Related Disorders; Dronabinol; Humans; Illicit Drugs; Marijuana Abuse; Meth | 2012 |
Amphetamine-like stimulants hit the headlines.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Humans | 2012 |
Amphetamine stimulates Wnt3 increases in rat nucleus accumbens.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Blotting, Western; Central Nervous System Stimu | 2012 |
[Usefulness of AccuSign in emergency room].
Topics: Amphetamine; Amphetamine-Related Disorders; Chromatography, Affinity; Diagnosis, Differential; Emerg | 2012 |
Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Calcium-Calmodulin-Dependent Protein Kinase Typ | 2013 |
Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Depression; Disease Mo | 2013 |
Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Basal Ganglia; Cyclic AMP Response Element-Bind | 2002 |
Cocaine-amphetamine regulated transcript (CART) expression is not regulated by amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Drug Administration Schedule; Hypothalamus; Mal | 2002 |
Intravenous self-administration of amphetamine is increased in a rat model of depression.
Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Behavior, Animal; Central | 2002 |
Repeated, intermittent treatment with amphetamine induces neurite outgrowth in rat pheochromocytoma cells (PC12 cells).
Topics: Adaptation, Physiological; Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Cocaine; Dopa | 2002 |
One step and highly sensitive headspace solid-phase microextraction sample preparation approach for the analysis of methamphetamine and amphetamine in human urine.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Gas Chromatography-Ma | 2002 |
Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benzopyrans; Cyclic AMP Response Element-Bindin | 2002 |
Exposure to chronic mild stress alters thresholds for lateral hypothalamic stimulation reward and subsequent responsiveness to amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Chronic Dise | 2002 |
Consequences of amygdala kindling and repeated withdrawal from ethanol on amphetamine-induced behaviours.
Topics: Action Potentials; Alcohol Withdrawal Seizures; Amphetamine; Amphetamine-Related Disorders; Amygdala | 2002 |
Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine.
Topics: Age Factors; Aging; Amphetamine; Amphetamine-Related Disorders; Animals; Caudate Nucleus; Cocaine; C | 2002 |
Compartment-specific changes in striatal neuronal activity during expression of amphetamine sensitization are the result of drug hypersensitivity.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Drug Toleranc | 2002 |
Neonatal administration of monosodium glutamate prevents the development of ethanol- but not psychostimulant-induced sensitization: a putative role of the arcuate nucleus.
Topics: Alcoholism; Amphetamine; Amphetamine-Related Disorders; Animals; Animals, Newborn; Arcuate Nucleus o | 2003 |
Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimul | 2003 |
[Therapeutic effects and hazards of amphetamine or psychotonic amines; drug addiction and hallucinatory delusions caused by orthedrine].
Topics: Amines; Amphetamine; Amphetamine-Related Disorders; Amphetamines; Delusions; Hallucinations; Humans; | 1953 |
The occurrence of paranoid incidents and abstinence delirium in abusers of amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Delirium; Humans; Paranoid Disorders; Subs | 1959 |
Clinical and biochemical studies of an amphetamine withdrawal psychosis.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Humans; Mental Disorders; Psychotic Disord | 1961 |
[Mixed toxicomania for amphetamines and oxazine derivatives in young patients].
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Behavior, Addictive; Humans; Oxazines; Phe | 1960 |
DIAGNOSIS OF AMPHETAMINE ADDICTION.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Barbiturates; Diagnosis; Substance-Related | 1965 |
DIAGNOSIS OF AMPHETAMINE ADDICTION.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Body Fluids; Chemistry Techniques, Analyti | 1965 |
DIAGNOSIS OF AMPHETAMINE ADDICTION.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Body Fluids; Chromatography; Substance-Rel | 1965 |
[Psychoses due to amphetamine abuse].
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Humans; Mental Disorders; Psychoses, Subst | 1959 |
Habituation and addiction to amphetamines.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Behavior, Addictive; Humans; Substance-Rel | 1962 |
A diet promoting sugar dependency causes behavioral cross-sensitization to a low dose of amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimul | 2003 |
A case of recurrent psychosis associated with amphetamine addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Humans; Mental Disorders; Psychotic Disord | 1950 |
Amphetamine and addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Behavior, Addictive; Humans | 1952 |
mGluR5-dependent increases in immediate early gene expression in the rat striatum following acute administration of amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Cerebral Cortex; Corpus Striatum; Disease Model | 2004 |
Increases in the density of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for corticotropin-releasing factor in sustained elevation.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Calbindin 1; Calbindin 2; Calbindins; Calcium-B | 2005 |
The development and initial validation of a questionnaire to measure craving for amphetamine.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Female; Humans; Intention; Male; Midd | 2004 |
[Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Cannabis; Cocaine; Cocaine-Related Di | 2004 |
The psychogenetically selected Roman rat lines differ in the susceptibility to develop amphetamine sensitization.
Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Avoidance Learning; Behav | 2005 |
[Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectional Studi | 2005 |
Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Apoptosis; Basal Ganglia Diseases; Corpus Stria | 2005 |
Environment makes amphetamine-induced dopamine release in the nucleus accumbens totally impulse-dependent.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Disease Models, Animal; Dopamine; Dopamine Upta | 2005 |
Intracerebral hemorrhage associated with amphetamine.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Cerebral Hemorrhage; Chromatography, Liquid; Fata | 2005 |
Abnormally high concentrations of amphetamine in blood of impaired drivers.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Benzodiazepines; Central Nerv | 2005 |
Personality and the subjective effects of acute amphetamine in healthy volunteers.
Topics: Adolescent; Adult; Affect; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimul | 2006 |
Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers.
Topics: Accidents, Traffic; Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Automobile Drivin | 2006 |
Amphetamine: the Janus of treatment for obesity.
Topics: Amphetamine; Amphetamine-Related Disorders; Appetite Depressants; Humans; Obesity | 1994 |
Relation between blood- and urine-amphetamine concentrations in impaired drivers as influenced by urinary pH and creatinine.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Central Nervous System Stimul | 2005 |
Quantitative and isomeric determination of amphetamine and methamphetamine from urine using a nonprotic elution solvent and R(-)-alpha-methoxy-alpha-trifluoromethylphenylacetic acid chloride derivatization.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Forensic Medicine; Hu | 2005 |
Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum.
Topics: Aminoacetonitrile; Amphetamine; Amphetamine-Related Disorders; Animals; Butadienes; Corpus Striatum; | 2006 |
Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benzazepines; Cerebral Cortex; Disease Models, | 2006 |
Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Cyclic AMP-Dependent Protein Kinases; Disease M | 2006 |
Amphetamine withdrawal leads to behavioral sensitization and reduced HPA axis response following amphetamine challenge.
Topics: Adrenocorticotropic Hormone; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; | 2006 |
Amphetamine exposure is elevated in Parkinson's disease.
Topics: Adrenergic Agents; Aged; Amphetamine; Amphetamine-Related Disorders; Amyotrophic Lateral Sclerosis; | 2006 |
A rapid and convenient LC/MS method for routine identification of methamphetamine/dimethylamphetamine and their metabolites in urine.
Topics: Amphetamine; Amphetamine-Related Disorders; Chromatography, Liquid; Humans; Mass Spectrometry; Metha | 2007 |
Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Brain Chemistry; Disease Models, Animal; | 2006 |
Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Apoptosis; Caspases; Cell Line, Tumor; Central | 2006 |
Tryptophan-deficient diet increases the neurochemical and behavioral response to amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Brain Chemistry; Corpus Striatum; Diseas | 2006 |
Fatal amphetamine-associated cardiotoxicity and its medicolegal implications.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Ce | 2006 |
Identification and quantification of change in Australian illicit drug markets.
Topics: Amphetamine; Amphetamine-Related Disorders; Cluster Analysis; Cocaine; Cocaine-Related Disorders; Dr | 2006 |
Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine.
Topics: Action Potentials; Adaptation, Physiological; Amphetamine; Amphetamine-Related Disorders; Animals; C | 2006 |
Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Chromatograp | 2007 |
Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Amphetamine-Related Disorders; Animals; Body Temperatur | 2006 |
Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Arousal; Behavior, Animal; Cyclic AMP Response | 2006 |
Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Cholecystokinin; Condi | 2006 |
Simultaneous determination of methamphetamine and its metabolite, amphetamine, in urine using a high performance liquid chromatography column-switching method.
Topics: Amphetamine; Amphetamine-Related Disorders; Chromatography, High Pressure Liquid; Hydrogen-Ion Conce | 2007 |
Single hair analysis of methamphetamine and amphetamine by solid phase microextraction coupled with in matrix derivatization.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Female; Gas Chromatography-Mass Spectrometry; Hai | 2006 |
Differential effects of chronic amphetamine and baclofen administration on cAMP levels and phosphorylation of CREB in distinct brain regions of wild type and monoamine oxidase B-deficient mice.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Baclofen; Biogenic Monoamines; Brain; Central N | 2006 |
Effects of environmental enrichment on extinction and reinstatement of amphetamine self-administration and sucrose-maintained responding.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning | 2006 |
Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Calcium Channels, L-Type; Central Nervous Syste | 2006 |
Priapism and quetiapine: a case report.
Topics: Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Comorbidity; Depressive Disorder; | 2006 |
Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benztropine; Binding, Competitive; Brain; Brain | 2007 |
Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Exploratory | 2007 |
[Severe anterior myocardial infarction caused by amphetamine abuse].
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Fatal Outcome; | 2007 |
[Diagnostics and interpretation of results in forensic toxicology of amphetamines].
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Body Fluids; Brain Chemistry; Chromatograp | 2006 |
Amphetamine reward in the monogamous prairie vole.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Amphetamine-Related Disorders; Animals; Arvicolinae; Cond | 2007 |
Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dose-Respons | 2007 |
Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment.
Topics: Adult; Age Factors; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Central Nervous | 2007 |
A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Buffers; Corpus Striatum; Cytosol; Dopam | 2007 |
Bimodal effect of amphetamine on motor behaviors in C57BL/6 mice.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Central Nervous System | 2007 |
Age- and sex-dependent amphetamine self-administration in rats.
Topics: Age Factors; Amphetamine; Amphetamine-Related Disorders; Animals; Appetitive Behavior; Disease Model | 2008 |
School-based administration of ADHD drugs decline, along with diversion, theft, and misuse.
Topics: Amphetamine; Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Attitude | 2007 |
Reverse or inverted left ventricular apical ballooning syndrome (reverse Takotsubo cardiomyopathy) in a young woman in the setting of amphetamine use.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Echocardiograp | 2008 |
Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans.
Topics: Adolescent; Adult; Aged; Amphetamine; Amphetamine-Related Disorders; Appetitive Behavior; Associatio | 2008 |
Hospitalizations with amphetamine abuse among pregnant women.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Amphetamine-Related Disorders; Chi-Square Distribution; | 2008 |
Upregulation of metabotropic glutamate receptor 8 mRNA expression in the rat forebrain after repeated amphetamine administration.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Corpus Stria | 2008 |
The absence of evidence is not the same as evidence for absence!
Topics: Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Central Nervous System Stimulants; H | 2008 |
Development of a reference material using methamphetamine abusers' hair samples for the determination of methamphetamine and amphetamine in hair.
Topics: Amphetamine; Amphetamine-Related Disorders; Gas Chromatography-Mass Spectrometry; Hair; Humans; Meth | 2008 |
Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood.
Topics: Adult; Age Factors; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Central Nervous | 2008 |
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anti-Bacterial Agents; Ceftriaxone; Clorazepate | 2008 |
Opposite environmental regulation of heroin and amphetamine self-administration in the rat.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning | 2008 |
Urinary excretion of amphetamine after termination of drug abuse.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Creatinine; Female; Gas Chromatograph | 1997 |
Identification of famprofazone ingestion.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Analgesics; Analgesics, Non-Narcotic; Anti-Inflam | 1998 |
[Ecstasy and related drugs in biological materials].
Topics: Amphetamine; Amphetamine-Related Disorders; Drug Overdose; Hallucinogens; Humans; Immunologic Techni | 1999 |
RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain Chemistry; Dopamine Uptake Inhibitors; Do | 1999 |
HPLC with fluorescence detection of methamphetamine and amphetamine in segmentally analyzed human hair.
Topics: Amphetamine; Amphetamine-Related Disorders; Chromatography, High Pressure Liquid; Hair; Humans; Meth | 1999 |
[Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
Topics: Amphetamine; Amphetamine-Related Disorders; Cocaine; Cocaine-Related Disorders; Denmark; Drug Overdo | 1999 |
Amphetamine withdrawal alters bistable states and cellular coupling in rat prefrontal cortex and nucleus accumbens neurons recorded in vivo.
Topics: Action Potentials; Amphetamine; Amphetamine-Related Disorders; Animals; Antibodies; Brain Chemistry; | 2000 |
Amphetamine misuse and social phobia.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Corpus Striatum; Dopamine; Female; Humans; Phobic | 2000 |
Differential effects of discrete subarea-specific lesions of the rat medial prefrontal cortex on amphetamine- and cocaine-induced behavioural sensitization.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Cocaine; Cocaine-Related Diso | 2000 |
Differential regulation of calmodulin content and calmodulin messenger RNA levels by acute and repeated, intermittent amphetamine in dopaminergic terminal and midbrain areas.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Calmodulin; Dopamine; Dose-Response Relationshi | 2000 |
Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Astrocytes; Dopamine; Dose-Response Relationshi | 2000 |
Amphetamine blocks long-term synaptic depression in the ventral tegmental area.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dopamine; Do | 2000 |
Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons.
Topics: Action Potentials; Afferent Pathways; Amphetamine; Amphetamine-Related Disorders; Animals; Dopamine; | 2000 |
GABA(B) receptors: altered coupling to G-proteins in rats sensitized to amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Baclofen; Dopamine; Drug Administration Schedul | 2000 |
Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Depre | 2000 |
Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Autopsy; Brain; Brain Chemistry; Cause of Death; | 2001 |
Effect of amphetamine on the expression of the metabotropic glutamate receptor 5 mRNA in developing rat brain.
Topics: Adrenergic Agents; Age Factors; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Anima | 2000 |
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; | 2001 |
Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Caudate Nucleus; Central Nerv | 2001 |
A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Benzazepines; Brain; | 2001 |
Amphetamine-induced plasticity of AMPA receptors in the ventral tegmental area: effects on extracellular levels of dopamine and glutamate in freely moving rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Disease Models, Animal; Dopamine; Extracellular | 2001 |
Maturational increases in c-fos expression in the ascending dopamine systems.
Topics: Age Factors; Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; | 2001 |
[Amphetamine-induced psychosis].
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Male; | 1998 |
Incentive sensitization by previous amphetamine exposure: increased cue-triggered "wanting" for sucrose reward.
Topics: Acoustic Stimulation; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Conditi | 2001 |
In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Dopamine; Dose-Response Relationship, Drug; Dru | 2002 |
Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Association Learning; Behavior, Animal; Central | 2002 |
Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Disease Models, Animal; Dopam | 2002 |
CaMKII regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amphetamine; Amphetamine-Related Disorders; Animals; | 2002 |
Spontaneous novelty seeking and amphetamine-induced conditioning and sensitization in adult mice: evidence of dissociation as a function of age at weaning.
Topics: Aging; Amphetamine; Amphetamine-Related Disorders; Animals; Animals, Newborn; Behavior, Animal; Cond | 2002 |